id	sid	tid	token	lemma	pos
gra-1881	1	1	introduction	introduction	NOUN
gra-1881	1	2	world	world	NOUN
gra-1881	1	3	-	-	PUNCT
gra-1881	1	4	wide	wide	ADV
gra-1881	1	5	,	,	PUNCT
gra-1881	1	6	the	the	DET
gra-1881	1	7	head	head	NOUN
gra-1881	1	8	and	and	CCONJ
gra-1881	1	9	neck	neck	NOUN
gra-1881	1	10	cancers	cancer	NOUN
gra-1881	1	11	are	be	AUX
gra-1881	1	12	the	the	DET
gra-1881	1	13	sixth	sixth	ADJ
gra-1881	1	14	most	most	ADV
gra-1881	1	15	common	common	ADJ
gra-1881	1	16	cancer	cancer	NOUN
gra-1881	1	17	.	.	PUNCT
gra-1881	2	1	it	it	PRON
gra-1881	2	2	is	be	AUX
gra-1881	2	3	the	the	DET
gra-1881	2	4	most	most	ADV
gra-1881	2	5	common	common	ADJ
gra-1881	2	6	cancer	cancer	NOUN
gra-1881	2	7	in	in	ADP
gra-1881	2	8	developing	develop	VERB
gra-1881	2	9	countries	country	NOUN
gra-1881	2	10	.	.	PUNCT
gra-1881	3	1	in	in	ADP
gra-1881	3	2	india	india	PROPN
gra-1881	3	3	it	it	PRON
gra-1881	3	4	is	be	AUX
gra-1881	3	5	the	the	DET
gra-1881	3	6	most	most	ADV
gra-1881	3	7	common	common	ADJ
gra-1881	3	8	cancer	cancer	NOUN
gra-1881	3	9	of	of	ADP
gra-1881	3	10	males	male	NOUN
gra-1881	3	11	and	and	CCONJ
gra-1881	3	12	the	the	DET
gra-1881	3	13	fth	fth	ADJ
gra-1881	3	14	most	most	ADV
gra-1881	3	15	common	common	ADJ
gra-1881	3	16	in	in	ADP
gra-1881	3	17	females	female	NOUN
gra-1881	3	18	.	.	PUNCT
gra-1881	4	1	cigarette	cigarette	NOUN
gra-1881	4	2	-	-	PUNCT
gra-1881	4	3	smoking	smoking	NOUN
gra-1881	4	4	and	and	CCONJ
gra-1881	4	5	alcohol	alcohol	NOUN
gra-1881	4	6	consumption	consumption	NOUN
gra-1881	4	7	are	be	AUX
gra-1881	4	8	the	the	DET
gra-1881	4	9	main	main	ADJ
gra-1881	4	10	reasons	reason	NOUN
gra-1881	4	11	for	for	ADP
gra-1881	4	12	hnscc	hnscc	NOUN
gra-1881	4	13	in	in	ADP
gra-1881	4	14	the	the	DET
gra-1881	4	15	western	western	ADJ
gra-1881	4	16	population	population	NOUN
gra-1881	4	17	,	,	PUNCT
gra-1881	4	18	whereas	whereas	SCONJ
gra-1881	4	19	the	the	DET
gra-1881	4	20	use	use	NOUN
gra-1881	4	21	of	of	ADP
gra-1881	4	22	smokeless	smokeless	NOUN
gra-1881	4	23	tobacco	tobacco	NOUN
gra-1881	4	24	and	and	CCONJ
gra-1881	4	25	areca	areca	PROPN
gra-1881	4	26	nut	nut	NOUN
gra-1881	4	27	is	be	AUX
gra-1881	4	28	the	the	DET
gra-1881	4	29	most	most	ADV
gra-1881	4	30	common	common	ADJ
gra-1881	4	31	cause	cause	NOUN
gra-1881	4	32	of	of	ADP
gra-1881	4	33	hnscc	hnscc	NOUN
gra-1881	4	34	in	in	ADP
gra-1881	4	35	.[1	.[1	ADJ
gra-1881	4	36	]	]	X
gra-1881	5	1	southeast	southeast	PROPN
gra-1881	5	2	asia	asia	PROPN
gra-1881	5	3	.	.	PUNCT
gra-1881	6	1	in	in	ADP
gra-1881	6	2	india	india	PROPN
gra-1881	6	3	,	,	PUNCT
gra-1881	6	4	nearly	nearly	ADV
gra-1881	6	5	two	two	NUM
gra-1881	6	6	-	-	PUNCT
gra-1881	6	7	thirds	third	NOUN
gra-1881	6	8	of	of	ADP
gra-1881	6	9	patients	patient	NOUN
gra-1881	6	10	present	present	ADJ
gra-1881	6	11	with	with	ADP
gra-1881	6	12	advanced	advanced	ADJ
gra-1881	6	13	stages	stage	NOUN
gra-1881	6	14	.	.	PUNCT
gra-1881	7	1	the	the	DET
gra-1881	7	2	mean	mean	ADJ
gra-1881	7	3	age	age	NOUN
gra-1881	7	4	of	of	ADP
gra-1881	7	5	patients	patient	NOUN
gra-1881	7	6	at	at	ADP
gra-1881	7	7	presentation	presentation	NOUN
gra-1881	7	8	of	of	ADP
gra-1881	7	9	head	head	NOUN
gra-1881	7	10	and	and	CCONJ
gra-1881	7	11	neck	neck	NOUN
gra-1881	7	12	cancers	cancer	NOUN
gra-1881	7	13	is	be	AUX
gra-1881	7	14	the	the	DET
gra-1881	7	15	fth	fth	ADJ
gra-1881	7	16	and	and	CCONJ
gra-1881	7	17	early	early	ADJ
gra-1881	7	18	sixth	sixth	ADJ
gra-1881	7	19	decades	decade	NOUN
gra-1881	7	20	in	in	ADP
gra-1881	7	21	asian	asian	ADJ
gra-1881	7	22	populations	population	NOUN
gra-1881	7	23	compared	compare	VERB
gra-1881	7	24	with	with	ADP
gra-1881	7	25	the	the	DET
gra-1881	7	26	seventh	seventh	ADJ
gra-1881	7	27	and	and	CCONJ
gra-1881	7	28	eighth	eighth	ADJ
gra-1881	7	29	decades	decade	NOUN
gra-1881	7	30	in	in	ADP
gra-1881	7	31	[	[	PUNCT
gra-1881	7	32	1	1	NUM
gra-1881	7	33	-	-	NUM
gra-1881	7	34	3]the	3]the	NUM
gra-1881	7	35	north	north	ADJ
gra-1881	7	36	american	american	ADJ
gra-1881	7	37	population	population	NOUN
gra-1881	7	38	.	.	PUNCT
gra-1881	8	1	loco	loco	PROPN
gra-1881	8	2	regionally	regionally	ADV
gra-1881	8	3	advanced	advanced	ADJ
gra-1881	8	4	head	head	NOUN
gra-1881	8	5	and	and	CCONJ
gra-1881	8	6	neck	neck	NOUN
gra-1881	8	7	cancers(lahnc	cancers(lahnc	PROPN
gra-1881	8	8	)	)	PUNCT
gra-1881	9	1	i.e	i.e	PRON
gra-1881	9	2	stage	stage	NOUN
gra-1881	9	3	iii	iii	PROPN
gra-1881	9	4	&	&	CCONJ
gra-1881	9	5	iv	iv	NUM
gra-1881	9	6	comprise	comprise	VERB
gra-1881	9	7	>	>	X
gra-1881	9	8	60	60	NUM
gra-1881	9	9	%	%	NOUN
gra-1881	9	10	of	of	ADP
gra-1881	9	11	these	these	DET
gra-1881	9	12	tumours	tumour	NOUN
gra-1881	9	13	for	for	ADP
gra-1881	9	14	which	which	PRON
gra-1881	9	15	cure	cure	NOUN
gra-1881	9	16	rates	rate	NOUN
gra-1881	9	17	have	have	AUX
gra-1881	9	18	been	be	AUX
gra-1881	9	19	<	<	X
gra-1881	9	20	30	30	NUM
gra-1881	9	21	%	%	NOUN
gra-1881	9	22	,	,	PUNCT
gra-1881	9	23	with	with	ADP
gra-1881	9	24	notably	notably	ADV
gra-1881	9	25	high	high	ADJ
gra-1881	9	26	morbidity	morbidity	NOUN
gra-1881	9	27	for	for	ADP
gra-1881	9	28	surgical	surgical	ADJ
gra-1881	9	29	as	as	ADV
gra-1881	9	30	well	well	ADV
gra-1881	9	31	as	as	ADP
gra-1881	9	32	non	non	ADJ
gra-1881	9	33	surgical	surgical	ADJ
gra-1881	9	34	treatment	treatment	NOUN
gra-1881	9	35	and	and	CCONJ
gra-1881	9	36	therefore	therefore	ADV
gra-1881	9	37	prognosis	prognosis	NOUN
gra-1881	9	38	remained	remain	VERB
gra-1881	9	39	poor	poor	ADJ
gra-1881	9	40	in	in	ADP
gra-1881	9	41	this	this	DET
gra-1881	9	42	group	group	NOUN
gra-1881	9	43	of	of	ADP
gra-1881	9	44	patients	patient	NOUN
gra-1881	9	45	and	and	CCONJ
gra-1881	9	46	this	this	PRON
gra-1881	9	47	has	have	VERB
gra-1881	9	48	[	[	X
gra-1881	9	49	4]remained	4]remaine	VERB
gra-1881	9	50	unchanged	unchanged	ADJ
gra-1881	9	51	over	over	ADP
gra-1881	9	52	the	the	DET
gra-1881	9	53	past	past	ADJ
gra-1881	9	54	30	30	NUM
gra-1881	9	55	yrs	yr	NOUN
gra-1881	9	56	.	.	PUNCT
gra-1881	10	1	in	in	ADP
gra-1881	10	2	meta	meta	ADJ
gra-1881	10	3	analysis	analysis	NOUN
gra-1881	10	4	reported	report	VERB
gra-1881	10	5	in	in	ADP
gra-1881	10	6	2000	2000	NUM
gra-1881	10	7	,	,	PUNCT
gra-1881	10	8	comparison	comparison	NOUN
gra-1881	10	9	of	of	ADP
gra-1881	10	10	local	local	ADJ
gra-1881	10	11	treatment	treatment	NOUN
gra-1881	10	12	with	with	ADP
gra-1881	10	13	or	or	CCONJ
gra-1881	10	14	without	without	ADP
gra-1881	10	15	chemotherapy	chemotherapy	NOUN
gra-1881	10	16	yielded	yield	VERB
gra-1881	10	17	an	an	DET
gra-1881	10	18	absolute	absolute	ADJ
gra-1881	10	19	benet	benet	NOUN
gra-1881	10	20	of	of	ADP
gra-1881	10	21	4	4	NUM
gra-1881	10	22	%	%	NOUN
gra-1881	10	23	in	in	ADP
gra-1881	10	24	overall	overall	ADJ
gra-1881	10	25	survival	survival	NOUN
gra-1881	10	26	(	(	PUNCT
gra-1881	10	27	os	os	NOUN
gra-1881	10	28	)	)	PUNCT
gra-1881	10	29	at	at	ADP
gra-1881	10	30	2	2	NUM
gra-1881	10	31	and	and	CCONJ
gra-1881	10	32	5	5	NUM
gra-1881	10	33	yrs	yr	NOUN
gra-1881	10	34	.	.	PUNCT
gra-1881	11	1	in	in	ADP
gra-1881	11	2	favour	favour	NOUN
gra-1881	11	3	of	of	ADP
gra-1881	11	4	chemotherapy	chemotherapy	NOUN
gra-1881	11	5	.	.	PUNCT
gra-1881	12	1	when	when	SCONJ
gra-1881	12	2	analysing	analyse	VERB
gra-1881	12	3	the	the	DET
gra-1881	12	4	data	datum	NOUN
gra-1881	12	5	for	for	ADP
gra-1881	12	6	concomitant	concomitant	ADJ
gra-1881	12	7	chemo	chemo	NOUN
gra-1881	12	8	-	-	PUNCT
gra-1881	12	9	radiotherapy	radiotherapy	NOUN
gra-1881	12	10	,	,	PUNCT
gra-1881	12	11	survival	survival	NOUN
gra-1881	12	12	benet	benet	PROPN
gra-1881	12	13	was	be	AUX
gra-1881	12	14	8	8	NUM
gra-1881	12	15	%	%	NOUN
gra-1881	12	16	at	at	ADP
gra-1881	12	17	5	5	NUM
gra-1881	12	18	yrs	yr	NOUN
gra-1881	12	19	.	.	PUNCT
gra-1881	13	1	an	an	DET
gra-1881	13	2	update	update	NOUN
gra-1881	13	3	of	of	ADP
gra-1881	13	4	this	this	DET
gra-1881	13	5	analysis	analysis	NOUN
gra-1881	13	6	focusing	focus	VERB
gra-1881	13	7	on	on	ADP
gra-1881	13	8	chemo	chemo	NOUN
gra-1881	13	9	-	-	PUNCT
gra-1881	13	10	radiotherapy	radiotherapy	NOUN
gra-1881	13	11	(	(	PUNCT
gra-1881	13	12	with	with	ADP
gra-1881	13	13	additional	additional	ADJ
gra-1881	13	14	24	24	NUM
gra-1881	13	15	trials	trial	NOUN
gra-1881	13	16	)	)	PUNCT
gra-1881	13	17	show	show	VERB
gra-1881	13	18	a	a	DET
gra-1881	13	19	4.5	4.5	NUM
gra-1881	13	20	%	%	NOUN
gra-1881	13	21	overall	overall	ADJ
gra-1881	13	22	survival	survival	NOUN
gra-1881	13	23	(	(	PUNCT
gra-1881	13	24	os	os	NOUN
gra-1881	13	25	)	)	PUNCT
gra-1881	13	26	for	for	ADP
gra-1881	13	27	all	all	PRON
gra-1881	13	28	and	and	CCONJ
gra-1881	13	29	6.5	6.5	NUM
gra-1881	13	30	%	%	NOUN
gra-1881	13	31	(	(	PUNCT
gra-1881	13	32	p	p	NOUN
gra-1881	13	33	value	value	NOUN
gra-1881	13	34	<	<	X
gra-1881	13	35	0.0001	0.0001	NUM
gra-1881	13	36	)	)	PUNCT
gra-1881	13	37	for	for	ADP
gra-1881	13	38	patients	patient	NOUN
gra-1881	13	39	who	who	PRON
gra-1881	13	40	received	receive	VERB
gra-1881	13	41	[	[	PUNCT
gra-1881	13	42	5]concurrent	5]concurrent	NUM
gra-1881	13	43	chemo	chemo	NOUN
gra-1881	13	44	-	-	PUNCT
gra-1881	13	45	radiotherapy	radiotherapy	NOUN
gra-1881	13	46	.	.	PUNCT
gra-1881	14	1	the	the	DET
gra-1881	14	2	advent	advent	NOUN
gra-1881	14	3	of	of	ADP
gra-1881	14	4	concurrent	concurrent	ADJ
gra-1881	14	5	chemo	chemo	NOUN
gra-1881	14	6	radiation	radiation	NOUN
gra-1881	14	7	has	have	AUX
gra-1881	14	8	signicantly	signicantly	ADV
gra-1881	14	9	contributed	contribute	VERB
gra-1881	14	10	to	to	ADP
gra-1881	14	11	the	the	DET
gra-1881	14	12	curability	curability	NOUN
gra-1881	14	13	of	of	ADP
gra-1881	14	14	head	head	NOUN
gra-1881	14	15	and	and	CCONJ
gra-1881	14	16	neck	neck	NOUN
gra-1881	14	17	cancers	cancer	NOUN
gra-1881	14	18	including	include	VERB
gra-1881	14	19	the	the	DET
gra-1881	14	20	loco	loco	NOUN
gra-1881	14	21	regionally	regionally	ADV
gra-1881	14	22	advanced	advanced	ADJ
gra-1881	14	23	stages	stage	NOUN
gra-1881	14	24	.	.	PUNCT
gra-1881	15	1	radiation	radiation	NOUN
gra-1881	15	2	with	with	ADP
gra-1881	15	3	concurrent	concurrent	ADJ
gra-1881	15	4	single	single	ADJ
gra-1881	15	5	agent	agent	NOUN
gra-1881	15	6	cisplatin	cisplatin	NOUN
gra-1881	15	7	has	have	AUX
gra-1881	15	8	been	be	AUX
gra-1881	15	9	established	establish	VERB
gra-1881	15	10	as	as	ADP
gra-1881	15	11	standard	standard	NOUN
gra-1881	15	12	of	of	ADP
gra-1881	15	13	care	care	NOUN
gra-1881	15	14	in	in	ADP
gra-1881	15	15	the	the	DET
gra-1881	15	16	management	management	NOUN
gra-1881	15	17	of	of	ADP
gra-1881	15	18	patients	patient	NOUN
gra-1881	15	19	with	with	ADP
gra-1881	15	20	unresectable	unresectable	ADJ
gra-1881	15	21	head	head	NOUN
gra-1881	15	22	and	and	CCONJ
gra-1881	15	23	neck	neck	NOUN
gra-1881	15	24	cancers	cancer	NOUN
gra-1881	15	25	.	.	PUNCT
gra-1881	16	1	previously	previously	ADV
gra-1881	16	2	3	3	NUM
gra-1881	16	3	weekly	weekly	ADJ
gra-1881	16	4	cisplatin	cisplatin	NOUN
gra-1881	16	5	regimen	regiman	NOUN
gra-1881	16	6	with	with	ADP
gra-1881	16	7	concurrent	concurrent	ADJ
gra-1881	16	8	radiotherapy	radiotherapy	NOUN
gra-1881	16	9	was	be	AUX
gra-1881	16	10	consid	consid	ADV
gra-1881	16	11	ered	ered	ADJ
gra-1881	16	12	to	to	PART
gra-1881	16	13	be	be	AUX
gra-1881	16	14	the	the	DET
gra-1881	16	15	standard	standard	ADJ
gra-1881	16	16	treatment	treatment	NOUN
gra-1881	16	17	in	in	ADP
gra-1881	16	18	patients	patient	NOUN
gra-1881	16	19	with	with	ADP
gra-1881	16	20	unresectable	unresectable	ADJ
gra-1881	16	21	hnscc	hnscc	NOUN
gra-1881	16	22	but	but	CCONJ
gra-1881	16	23	it	it	PRON
gra-1881	16	24	was	be	AUX
gra-1881	16	25	also	also	ADV
gra-1881	16	26	seen	see	VERB
gra-1881	16	27	that	that	SCONJ
gra-1881	16	28	it	it	PRON
gra-1881	16	29	was	be	AUX
gra-1881	16	30	associ	associ	PRON
gra-1881	16	31	ated	ate	VERB
gra-1881	16	32	with	with	ADP
gra-1881	16	33	signicant	signicant	ADJ
gra-1881	16	34	increase	increase	NOUN
gra-1881	16	35	in	in	ADP
gra-1881	16	36	toxicities	toxicity	NOUN
gra-1881	16	37	.	.	PUNCT
gra-1881	17	1	therefore	therefore	ADV
gra-1881	17	2	,	,	PUNCT
gra-1881	17	3	it	it	PRON
gra-1881	17	4	was	be	AUX
gra-1881	17	5	thought	think	VERB
gra-1881	17	6	that	that	SCONJ
gra-1881	17	7	splitting	split	VERB
gra-1881	17	8	this	this	DET
gra-1881	17	9	dose	dose	NOUN
gra-1881	17	10	as	as	ADP
gra-1881	17	11	weekly	weekly	ADJ
gra-1881	17	12	cisplatin	cisplatin	NOUN
gra-1881	17	13	might	might	AUX
gra-1881	17	14	decrease	decrease	VERB
gra-1881	17	15	toxicities	toxicity	NOUN
gra-1881	17	16	maintaining	maintain	VERB
gra-1881	17	17	the	the	DET
gra-1881	17	18	dose	dose	NOUN
gra-1881	17	19	intensity	intensity	NOUN
gra-1881	17	20	and	and	CCONJ
gra-1881	17	21	also	also	ADV
gra-1881	17	22	avoids	avoid	VERB
gra-1881	17	23	the	the	DET
gra-1881	17	24	problem	problem	NOUN
gra-1881	17	25	of	of	ADP
gra-1881	17	26	inadequate	inadequate	ADJ
gra-1881	17	27	inpatient	inpatient	NOUN
gra-1881	17	28	beds	bed	NOUN
gra-1881	17	29	and	and	CCONJ
gra-1881	17	30	delay	delay	NOUN
gra-1881	17	31	in	in	ADP
gra-1881	17	32	administration	administration	NOUN
gra-1881	17	33	of	of	ADP
gra-1881	17	34	chemotherapy	chemotherapy	NOUN
gra-1881	17	35	.	.	PUNCT
gra-1881	18	1	in	in	ADP
gra-1881	18	2	this	this	DET
gra-1881	18	3	background	background	NOUN
gra-1881	18	4	,	,	PUNCT
gra-1881	18	5	this	this	PRON
gra-1881	18	6	prospective	prospective	ADJ
gra-1881	18	7	,	,	PUNCT
gra-1881	18	8	institutional	institutional	ADJ
gra-1881	18	9	study	study	NOUN
gra-1881	18	10	was	be	AUX
gra-1881	18	11	undertaken	undertake	VERB
gra-1881	18	12	to	to	PART
gra-1881	18	13	compare	compare	VERB
gra-1881	18	14	the	the	DET
gra-1881	18	15	two	two	NUM
gra-1881	18	16	different	different	ADJ
gra-1881	18	17	chemotherapy	chemotherapy	NOUN
gra-1881	18	18	schedules	schedule	NOUN
gra-1881	18	19	given	give	VERB
gra-1881	18	20	concurrently	concurrently	ADV
gra-1881	18	21	with	with	ADP
gra-1881	18	22	radiotherapy	radiotherapy	NOUN
gra-1881	18	23	.	.	PUNCT
gra-1881	19	1	materials	material	NOUN
gra-1881	19	2	and	and	CCONJ
gra-1881	19	3	methods	method	NOUN
gra-1881	19	4	:	:	PUNCT
gra-1881	19	5	this	this	DET
gra-1881	19	6	prospective	prospective	ADJ
gra-1881	19	7	study	study	NOUN
gra-1881	19	8	was	be	AUX
gra-1881	19	9	conducted	conduct	VERB
gra-1881	19	10	on	on	ADP
gra-1881	19	11	50	50	NUM
gra-1881	19	12	histologically	histologically	NOUN
gra-1881	19	13	proven	prove	VERB
gra-1881	19	14	squamous	squamous	ADJ
gra-1881	19	15	cell	cell	NOUN
gra-1881	19	16	carcinoma	carcinoma	NOUN
gra-1881	19	17	lahnc(ajcc	lahnc(ajcc	PROPN
gra-1881	19	18	stage	stage	NOUN
gra-1881	19	19	iii	iii	NOUN
gra-1881	19	20	and	and	CCONJ
gra-1881	19	21	iv)inoperable	iv)inoperable	ADJ
gra-1881	19	22	patients	patient	NOUN
gra-1881	19	23	coming	come	VERB
gra-1881	19	24	to	to	ADP
gra-1881	19	25	this	this	DET
gra-1881	19	26	hospital	hospital	NOUN
gra-1881	19	27	between	between	ADP
gra-1881	19	28	age	age	NOUN
gra-1881	19	29	of	of	ADP
gra-1881	19	30	18	18	NUM
gra-1881	19	31	to	to	PART
gra-1881	19	32	55	55	NUM
gra-1881	19	33	years	year	NOUN
gra-1881	19	34	who	who	PRON
gra-1881	19	35	were	be	AUX
gra-1881	19	36	previously	previously	ADV
gra-1881	19	37	untreated	untreated	ADJ
gra-1881	19	38	.all	.all	SCONJ
gra-1881	19	39	patients	patient	NOUN
gra-1881	19	40	were	be	AUX
gra-1881	19	41	randomized	randomize	VERB
gra-1881	19	42	into	into	ADP
gra-1881	19	43	two	two	NUM
gra-1881	19	44	arms	arm	NOUN
gra-1881	19	45	of	of	ADP
gra-1881	19	46	25	25	NUM
gra-1881	19	47	patients	patient	NOUN
gra-1881	19	48	each	each	PRON
gra-1881	19	49	.	.	PUNCT
gra-1881	20	1	in	in	ADP
gra-1881	20	2	arm	arm	NOUN
gra-1881	20	3	a	a	DET
gra-1881	20	4	patients	patient	NOUN
gra-1881	20	5	received	receive	VERB
gra-1881	20	6	inj	inj	NOUN
gra-1881	20	7	cisplatin	cisplatin	NOUN
gra-1881	20	8	30mg	30mg	NUM
gra-1881	20	9	/	/	SYM
gra-1881	20	10	m2	m2	PROPN
gra-1881	20	11	weekly	weekly	ADJ
gra-1881	20	12	on	on	ADP
gra-1881	20	13	day	day	NOUN
gra-1881	20	14	1,8,15,22,29,36	1,8,15,22,29,36	NUM
gra-1881	20	15	given	give	VERB
gra-1881	20	16	concurrently	concurrently	ADV
gra-1881	20	17	along	along	ADP
gra-1881	20	18	with	with	ADP
gra-1881	20	19	standard	standard	ADJ
gra-1881	20	20	rad	rad	PROPN
gra-1881	20	21	iotherapy	iotherapy	NOUN
gra-1881	20	22	and	and	CCONJ
gra-1881	20	23	in	in	ADP
gra-1881	20	24	arm	arm	NOUN
gra-1881	20	25	b	b	PROPN
gra-1881	20	26	patients	patient	NOUN
gra-1881	20	27	will	will	AUX
gra-1881	20	28	receive	receive	VERB
gra-1881	20	29	inj	inj	NOUN
gra-1881	20	30	.	.	PUNCT
gra-1881	21	1	cisplatin	cisplatin	PROPN
gra-1881	21	2	100mg	100mg	PROPN
gra-1881	21	3	/	/	SYM
gra-1881	21	4	m2	m2	PROPN
gra-1881	21	5	on	on	ADP
gra-1881	21	6	a	a	DET
gra-1881	21	7	three	three	NUM
gra-1881	21	8	weekly	weekly	ADJ
gra-1881	21	9	basis	basis	NOUN
gra-1881	21	10	on	on	ADP
gra-1881	21	11	days	day	NOUN
gra-1881	21	12	1,22	1,22	NUM
gra-1881	21	13	given	give	VERB
gra-1881	21	14	concurrently	concurrently	ADV
gra-1881	21	15	along	along	ADP
gra-1881	21	16	with	with	ADP
gra-1881	21	17	standard	standard	ADJ
gra-1881	21	18	radiotherapy	radiotherapy	NOUN
gra-1881	21	19	.	.	PUNCT
gra-1881	22	1	patients	patient	NOUN
gra-1881	22	2	received	receive	VERB
gra-1881	22	3	radiotherapy	radiotherapy	NOUN
gra-1881	22	4	to	to	PART
gra-1881	22	5	dose	dose	VERB
gra-1881	22	6	of	of	ADP
gra-1881	22	7	70	70	NUM
gra-1881	22	8	gray(gy	gray(gy	NOUN
gra-1881	22	9	)	)	PUNCT
gra-1881	22	10	over	over	ADP
gra-1881	22	11	35	35	NUM
gra-1881	22	12	fractions	fraction	NOUN
gra-1881	22	13	(	(	PUNCT
gra-1881	22	14	#	#	NOUN
gra-1881	22	15	)	)	PUNCT
gra-1881	22	16	over	over	ADP
gra-1881	22	17	7	7	NUM
gra-1881	22	18	weeks	week	NOUN
gra-1881	22	19	with	with	ADP
gra-1881	22	20	5#/week	5#/week	NUM
gra-1881	22	21	@	@	ADP
gra-1881	22	22	2gy/	2gy/	NUM
gra-1881	22	23	#	#	NOUN
gra-1881	22	24	.the	.the	NOUN
gra-1881	22	25	theratron	theratron	NOUN
gra-1881	23	1	780c	780c	ADJ
gra-1881	23	2	tele	tele	NOUN
gra-1881	23	3	-	-	PUNCT
gra-1881	23	4	cobalt	cobalt	NOUN
gra-1881	23	5	machine	machine	NOUN
gra-1881	23	6	was	be	AUX
gra-1881	23	7	used	use	VERB
gra-1881	23	8	for	for	ADP
gra-1881	23	9	radiotherapy	radiotherapy	NOUN
gra-1881	23	10	of	of	ADP
gra-1881	23	11	the	the	DET
gra-1881	23	12	patients	patient	NOUN
gra-1881	23	13	after	after	SCONJ
gra-1881	23	14	convention	convention	NOUN
gra-1881	23	15	planning	planning	NOUN
gra-1881	23	16	by	by	ADP
gra-1881	23	17	radiation	radiation	NOUN
gra-1881	23	18	oncologist	oncologist	NOUN
gra-1881	23	19	for	for	ADP
gra-1881	23	20	assessment	assessment	NOUN
gra-1881	23	21	of	of	ADP
gra-1881	23	22	toxicity	toxicity	NOUN
gra-1881	23	23	all	all	DET
gra-1881	23	24	patients	patient	NOUN
gra-1881	23	25	were	be	AUX
gra-1881	23	26	monitored	monitor	VERB
gra-1881	23	27	weekly	weekly	ADV
gra-1881	23	28	during	during	ADP
gra-1881	23	29	the	the	DET
gra-1881	23	30	course	course	NOUN
gra-1881	23	31	of	of	ADP
gra-1881	23	32	ccrt	ccrt	NOUN
gra-1881	23	33	for	for	ADP
gra-1881	23	34	assessing	assess	VERB
gra-1881	23	35	the	the	DET
gra-1881	23	36	early	early	ADJ
gra-1881	23	37	toxicity	toxicity	NOUN
gra-1881	23	38	of	of	ADP
gra-1881	23	39	therapy	therapy	NOUN
gra-1881	23	40	.	.	PUNCT
gra-1881	24	1	response	response	NOUN
gra-1881	24	2	assessment	assessment	NOUN
gra-1881	24	3	:	:	PUNCT
gra-1881	24	4	for	for	ADP
gra-1881	24	5	assessment	assessment	NOUN
gra-1881	24	6	of	of	ADP
gra-1881	24	7	response	response	NOUN
gra-1881	24	8	recist	recist	NOUN
gra-1881	24	9	v1.01	v1.01	PROPN
gra-1881	24	10	was	be	AUX
gra-1881	24	11	used	use	VERB
gra-1881	24	12	.	.	PUNCT
gra-1881	25	1	com	com	NOUN
gra-1881	25	2	plete	plete	ADJ
gra-1881	25	3	response	response	NOUN
gra-1881	25	4	(	(	PUNCT
gra-1881	25	5	cr	cr	NOUN
gra-1881	25	6	)	)	PUNCT
gra-1881	25	7	was	be	AUX
gra-1881	25	8	dened	dene	VERB
gra-1881	25	9	as	as	ADP
gra-1881	25	10	the	the	DET
gra-1881	25	11	complete	complete	ADJ
gra-1881	25	12	abs	ab	NOUN
gra-1881	25	13	ence	ence	NOUN
gra-1881	25	14	of	of	ADP
gra-1881	25	15	disease	disease	NOUN
gra-1881	25	16	6	6	NUM
gra-1881	25	17	weeks	week	NOUN
gra-1881	25	18	.	.	PUNCT
gra-1881	26	1	partial	partial	ADJ
gra-1881	26	2	response	response	NOUN
gra-1881	26	3	(	(	PUNCT
gra-1881	26	4	pr	pr	NOUN
gra-1881	26	5	)	)	PUNCT
gra-1881	26	6	was	be	AUX
gra-1881	26	7	dened	dene	VERB
gra-1881	26	8	as	as	ADP
gra-1881	26	9	a	a	DET
gra-1881	26	10	reduction	reduction	NOUN
gra-1881	26	11	of	of	ADP
gra-1881	26	12	disease	disease	NOUN
gra-1881	26	13	by	by	ADP
gra-1881	26	14	at	at	ADV
gra-1881	26	15	least	least	ADV
gra-1881	26	16	50	50	NUM
gra-1881	26	17	%	%	NOUN
gra-1881	26	18	in	in	ADP
gra-1881	26	19	the	the	DET
gra-1881	26	20	sum	sum	NOUN
gra-1881	26	21	of	of	ADP
gra-1881	26	22	all	all	DET
gra-1881	26	23	measurable	measurable	ADJ
gra-1881	26	24	products	product	NOUN
gra-1881	26	25	of	of	ADP
gra-1881	26	26	the	the	DET
gra-1881	26	27	longest	long	ADJ
gra-1881	26	28	perpendicular	perpendicular	ADJ
gra-1881	26	29	diameters	diameter	NOUN
gra-1881	26	30	of	of	ADP
gra-1881	26	31	measurable	measurable	ADJ
gra-1881	26	32	tumor	tumor	NOUN
gra-1881	26	33	masses	masse	NOUN
gra-1881	26	34	for	for	ADP
gra-1881	26	35	at	at	ADV
gra-1881	26	36	least	least	ADV
gra-1881	26	37	6	6	NUM
gra-1881	26	38	weeks	week	NOUN
gra-1881	26	39	,	,	PUNCT
gra-1881	26	40	with	with	ADP
gra-1881	26	41	no	no	DET
gra-1881	26	42	evaluation	evaluation	NOUN
gra-1881	26	43	of	of	ADP
gra-1881	26	44	toxicity	toxicity	NOUN
gra-1881	26	45	and	and	CCONJ
gra-1881	26	46	compliance	compliance	NOUN
gra-1881	26	47	of	of	ADP
gra-1881	26	48	cisplatin	cisplatin	NOUN
gra-1881	26	49	given	give	VERB
gra-1881	26	50	weekly	weekly	NOUN
gra-1881	26	51	vs	vs	ADP
gra-1881	26	52	three	three	NUM
gra-1881	26	53	weekly	weekly	NOUN
gra-1881	26	54	concurrently	concurrently	ADV
gra-1881	26	55	with	with	ADP
gra-1881	26	56	radiotherapy	radiotherapy	NOUN
gra-1881	26	57	in	in	ADP
gra-1881	26	58	head	head	NOUN
gra-1881	26	59	and	and	CCONJ
gra-1881	26	60	neck	neck	NOUN
gra-1881	26	61	cancer	cancer	NOUN
gra-1881	26	62	original	original	ADJ
gra-1881	26	63	research	research	PROPN
gra-1881	26	64	paper	paper	PROPN
gra-1881	26	65	dr	dr	PROPN
gra-1881	26	66	.	.	PROPN
gra-1881	26	67	manish	manish	PROPN
gra-1881	26	68	verma	verma	PROPN
gra-1881	26	69	department	department	PROPN
gra-1881	26	70	of	of	ADP
gra-1881	26	71	radiation	radiation	NOUN
gra-1881	26	72	oncology	oncology	NOUN
gra-1881	26	73	,	,	PUNCT
gra-1881	26	74	government	government	NOUN
gra-1881	26	75	cancer	cancer	NOUN
gra-1881	26	76	hospital	hospital	NOUN
gra-1881	26	77	,	,	PUNCT
gra-1881	26	78	mgm	mgm	PROPN
gra-1881	26	79	medical	medical	PROPN
gra-1881	26	80	college	college	PROPN
gra-1881	26	81	,	,	PUNCT
gra-1881	26	82	indore-452001	indore-452001	ADJ
gra-1881	26	83	x	x	SYM
gra-1881	26	84	55gjra	55gjra	NUM
gra-1881	26	85	global	global	ADJ
gra-1881	26	86	journal	journal	NOUN
gra-1881	26	87	for	for	ADP
gra-1881	26	88	research	research	NOUN
gra-1881	26	89	analysis	analysis	NOUN
gra-1881	26	90	oncology	oncology	NOUN
gra-1881	26	91	background	background	NOUN
gra-1881	26	92	:	:	PUNCT
gra-1881	26	93	concurrent	concurrent	ADJ
gra-1881	26	94	chemoradiotherapy	chemoradiotherapy	NOUN
gra-1881	26	95	with	with	ADP
gra-1881	26	96	cisplatin	cisplatin	NOUN
gra-1881	26	97	is	be	AUX
gra-1881	26	98	widely	widely	ADV
gra-1881	26	99	accepted	accept	VERB
gra-1881	26	100	modality	modality	NOUN
gra-1881	26	101	of	of	ADP
gra-1881	26	102	treatment	treatment	NOUN
gra-1881	26	103	for	for	ADP
gra-1881	26	104	head	head	NOUN
gra-1881	26	105	and	and	CCONJ
gra-1881	26	106	neck	neck	NOUN
gra-1881	26	107	cancer	cancer	NOUN
gra-1881	26	108	.	.	PUNCT
gra-1881	27	1	aim	aim	NOUN
gra-1881	27	2	:	:	PUNCT
gra-1881	27	3	to	to	PART
gra-1881	27	4	compare	compare	VERB
gra-1881	27	5	three	three	NUM
gra-1881	27	6	weekly	weekly	ADJ
gra-1881	27	7	cisplatin	cisplatin	NOUN
gra-1881	27	8	and	and	CCONJ
gra-1881	27	9	weekly	weekly	ADJ
gra-1881	27	10	cisplatin	cisplatin	NOUN
gra-1881	27	11	given	give	VERB
gra-1881	27	12	concurrently	concurrently	ADV
gra-1881	27	13	along	along	ADP
gra-1881	27	14	with	with	ADP
gra-1881	27	15	external	external	ADJ
gra-1881	27	16	beam	beam	NOUN
gra-1881	27	17	radiotherapy	radiotherapy	NOUN
gra-1881	27	18	in	in	ADP
gra-1881	27	19	locally	locally	ADV
gra-1881	27	20	advanced	advanced	ADJ
gra-1881	27	21	head	head	NOUN
gra-1881	27	22	and	and	CCONJ
gra-1881	27	23	neck	neck	NOUN
gra-1881	27	24	cancers(lahnc	cancers(lahnc	PROPN
gra-1881	27	25	)	)	PUNCT
gra-1881	27	26	for	for	ADP
gra-1881	27	27	toxicity	toxicity	NOUN
gra-1881	27	28	and	and	CCONJ
gra-1881	27	29	response	response	NOUN
gra-1881	27	30	.	.	PUNCT
gra-1881	28	1	materials	material	NOUN
gra-1881	28	2	and	and	CCONJ
gra-1881	28	3	methods	method	NOUN
gra-1881	28	4	:	:	PUNCT
gra-1881	28	5	50	50	NUM
gra-1881	28	6	patients	patient	NOUN
gra-1881	28	7	of	of	ADP
gra-1881	28	8	lahnc	lahnc	NOUN
gra-1881	28	9	were	be	AUX
gra-1881	28	10	taken	take	VERB
gra-1881	28	11	for	for	ADP
gra-1881	28	12	this	this	DET
gra-1881	28	13	prospective	prospective	ADJ
gra-1881	28	14	study	study	NOUN
gra-1881	28	15	.	.	PUNCT
gra-1881	29	1	in	in	ADP
gra-1881	29	2	arm	arm	NOUN
gra-1881	29	3	a	a	DET
gra-1881	29	4	25	25	NUM
gra-1881	29	5	patients	patient	NOUN
gra-1881	29	6	received	receive	VERB
gra-1881	29	7	6	6	NUM
gra-1881	29	8	cycles	cycle	NOUN
gra-1881	29	9	of	of	ADP
gra-1881	29	10	weekly	weekly	ADJ
gra-1881	29	11	cisplatin	cisplatin	NOUN
gra-1881	29	12	30mg	30mg	NUM
gra-1881	29	13	/	/	SYM
gra-1881	29	14	m2along	m2along	NOUN
gra-1881	29	15	with	with	ADP
gra-1881	29	16	radiotherapy	radiotherapy	NOUN
gra-1881	29	17	and	and	CCONJ
gra-1881	29	18	in	in	ADP
gra-1881	29	19	arm	arm	NOUN
gra-1881	29	20	b	b	PROPN
gra-1881	29	21	2	2	NUM
gra-1881	29	22	cycles	cycle	NOUN
gra-1881	29	23	of	of	ADP
gra-1881	29	24	cisplatin	cisplatin	PROPN
gra-1881	29	25	100mg	100mg	PROPN
gra-1881	29	26	/	/	SYM
gra-1881	29	27	m2	m2	PROPN
gra-1881	29	28	given	give	VERB
gra-1881	29	29	3	3	NUM
gra-1881	29	30	weekly	weekly	ADV
gra-1881	29	31	along	along	ADP
gra-1881	29	32	with	with	ADP
gra-1881	29	33	radiotherapy	radiotherapy	NOUN
gra-1881	29	34	.	.	PUNCT
gra-1881	30	1	treatment	treatment	NOUN
gra-1881	30	2	response	response	NOUN
gra-1881	30	3	was	be	AUX
gra-1881	30	4	seen	see	VERB
gra-1881	30	5	at	at	ADP
gra-1881	30	6	the	the	DET
gra-1881	30	7	end	end	NOUN
gra-1881	30	8	of	of	ADP
gra-1881	30	9	treatment	treatment	NOUN
gra-1881	30	10	as	as	ADP
gra-1881	30	11	per	per	ADP
gra-1881	30	12	recist	recist	NOUN
gra-1881	30	13	v1.01	v1.01	PROPN
gra-1881	30	14	criteria	criterion	NOUN
gra-1881	30	15	.	.	PUNCT
gra-1881	31	1	all	all	DET
gra-1881	31	2	chemotherapy	chemotherapy	NOUN
gra-1881	31	3	toxicities	toxicity	NOUN
gra-1881	31	4	were	be	AUX
gra-1881	31	5	graded	grade	VERB
gra-1881	31	6	as	as	ADP
gra-1881	31	7	per	per	ADP
gra-1881	31	8	common	common	ADJ
gra-1881	31	9	toxicity	toxicity	NOUN
gra-1881	31	10	criteria	criterion	NOUN
gra-1881	31	11	v4.0	v4.0	X
gra-1881	31	12	and	and	CCONJ
gra-1881	31	13	all	all	DET
gra-1881	31	14	radiation	radiation	NOUN
gra-1881	31	15	toxicities	toxicity	NOUN
gra-1881	31	16	were	be	AUX
gra-1881	31	17	graded	grade	VERB
gra-1881	31	18	as	as	ADP
gra-1881	31	19	per	per	ADP
gra-1881	31	20	rtog	rtog	NOUN
gra-1881	31	21	toxicity	toxicity	NOUN
gra-1881	31	22	criteria	criterion	NOUN
gra-1881	31	23	.	.	PUNCT
gra-1881	32	1	student	student	NOUN
gra-1881	32	2	unpaired	unpaired	PROPN
gra-1881	32	3	t	t	PROPN
gra-1881	32	4	test	test	NOUN
gra-1881	32	5	was	be	AUX
gra-1881	32	6	used	use	VERB
gra-1881	32	7	for	for	ADP
gra-1881	32	8	statistical	statistical	ADJ
gra-1881	32	9	analysis	analysis	NOUN
gra-1881	32	10	.	.	PUNCT
gra-1881	33	1	observations	observation	NOUN
gra-1881	33	2	and	and	CCONJ
gra-1881	33	3	results	result	NOUN
gra-1881	33	4	:	:	PUNCT
gra-1881	33	5	in	in	ADP
gra-1881	33	6	our	our	PRON
gra-1881	33	7	study	study	NOUN
gra-1881	33	8	no	no	DET
gra-1881	33	9	signicant	signicant	ADJ
gra-1881	33	10	difference	difference	NOUN
gra-1881	33	11	was	be	AUX
gra-1881	33	12	seen	see	VERB
gra-1881	33	13	in	in	ADP
gra-1881	33	14	terms	term	NOUN
gra-1881	33	15	of	of	ADP
gra-1881	33	16	all	all	DET
gra-1881	33	17	measured	measure	VERB
gra-1881	33	18	toxicities	toxicity	NOUN
gra-1881	33	19	but	but	CCONJ
gra-1881	33	20	hematological	hematological	ADJ
gra-1881	33	21	toxicities	toxicity	NOUN
gra-1881	33	22	were	be	AUX
gra-1881	33	23	higher	high	ADJ
gra-1881	33	24	in	in	ADP
gra-1881	33	25	group	group	PROPN
gra-1881	33	26	b.	b.	PROPN
gra-1881	33	27	regarding	regard	VERB
gra-1881	33	28	acute	acute	PROPN
gra-1881	33	29	mucositis	mucositis	PROPN
gra-1881	33	30	and	and	CCONJ
gra-1881	33	31	dermatitis	dermatitis	NOUN
gra-1881	33	32	,	,	PUNCT
gra-1881	33	33	most	most	ADJ
gra-1881	33	34	of	of	ADP
gra-1881	33	35	them	they	PRON
gra-1881	33	36	were	be	AUX
gra-1881	33	37	grade	grade	NOUN
gra-1881	33	38	1	1	NUM
gra-1881	33	39	and	and	CCONJ
gra-1881	33	40	2	2	NUM
gra-1881	33	41	and	and	CCONJ
gra-1881	33	42	were	be	AUX
gra-1881	33	43	taken	take	VERB
gra-1881	33	44	care	care	NOUN
gra-1881	33	45	of	of	ADP
gra-1881	33	46	on	on	ADP
gra-1881	33	47	outpatient	outpatient	NOUN
gra-1881	33	48	care	care	NOUN
gra-1881	33	49	basis	basis	NOUN
gra-1881	33	50	.	.	PUNCT
gra-1881	34	1	with	with	SCONJ
gra-1881	34	2	regards	regard	NOUN
gra-1881	34	3	to	to	ADP
gra-1881	34	4	response	response	NOUN
gra-1881	34	5	to	to	ADP
gra-1881	34	6	treatment	treatment	NOUN
gra-1881	34	7	in	in	ADP
gra-1881	34	8	our	our	PRON
gra-1881	34	9	study	study	NOUN
gra-1881	34	10	cr	cr	NOUN
gra-1881	34	11	was	be	AUX
gra-1881	34	12	seen	see	VERB
gra-1881	34	13	in	in	ADP
gra-1881	34	14	56	56	NUM
gra-1881	34	15	%	%	NOUN
gra-1881	34	16	of	of	ADP
gra-1881	34	17	patients	patient	NOUN
gra-1881	34	18	in	in	ADP
gra-1881	34	19	group	group	PROPN
gra-1881	34	20	a	a	PROPN
gra-1881	34	21	and	and	CCONJ
gra-1881	34	22	54.5	54.5	NUM
gra-1881	34	23	%	%	NOUN
gra-1881	34	24	of	of	ADP
gra-1881	34	25	patients	patient	NOUN
gra-1881	34	26	in	in	ADP
gra-1881	34	27	group	group	PROPN
gra-1881	34	28	b	b	PROPN
gra-1881	34	29	while	while	SCONJ
gra-1881	34	30	3	3	NUM
gra-1881	34	31	(	(	PUNCT
gra-1881	34	32	12	12	NUM
gra-1881	34	33	%	%	NOUN
gra-1881	34	34	)	)	PUNCT
gra-1881	34	35	patients	patient	NOUN
gra-1881	34	36	had	have	VERB
gra-1881	34	37	stable	stable	ADJ
gra-1881	34	38	disease	disease	NOUN
gra-1881	34	39	and	and	CCONJ
gra-1881	34	40	6	6	NUM
gra-1881	34	41	(	(	PUNCT
gra-1881	34	42	24	24	NUM
gra-1881	34	43	%	%	NOUN
gra-1881	34	44	)	)	PUNCT
gra-1881	35	1	patients	patient	NOUN
gra-1881	35	2	had	have	VERB
gra-1881	35	3	partial	partial	ADJ
gra-1881	35	4	response	response	NOUN
gra-1881	35	5	in	in	ADP
gra-1881	35	6	group	group	NOUN
gra-1881	35	7	a	a	DET
gra-1881	35	8	while	while	NOUN
gra-1881	35	9	1	1	NUM
gra-1881	35	10	(	(	PUNCT
gra-1881	35	11	4.55	4.55	NUM
gra-1881	35	12	%	%	NOUN
gra-1881	35	13	)	)	PUNCT
gra-1881	35	14	patient	patient	NOUN
gra-1881	35	15	in	in	ADP
gra-1881	35	16	group	group	PROPN
gra-1881	35	17	b	b	PROPN
gra-1881	35	18	had	have	VERB
gra-1881	35	19	stable	stable	ADJ
gra-1881	35	20	disease	disease	NOUN
gra-1881	35	21	and	and	CCONJ
gra-1881	35	22	7	7	NUM
gra-1881	35	23	(	(	PUNCT
gra-1881	35	24	31.82	31.82	NUM
gra-1881	35	25	%	%	NOUN
gra-1881	35	26	)	)	PUNCT
gra-1881	36	1	patients	patient	NOUN
gra-1881	36	2	had	have	VERB
gra-1881	36	3	partial	partial	ADJ
gra-1881	36	4	response	response	NOUN
gra-1881	36	5	with	with	ADP
gra-1881	36	6	no	no	DET
gra-1881	36	7	signicant	signicant	ADJ
gra-1881	36	8	difference	difference	NOUN
gra-1881	36	9	between	between	ADP
gra-1881	36	10	both	both	DET
gra-1881	36	11	groups	group	NOUN
gra-1881	36	12	.	.	PUNCT
gra-1881	37	1	conclusion	conclusion	NOUN
gra-1881	37	2	:	:	PUNCT
gra-1881	37	3	weekly	weekly	ADJ
gra-1881	37	4	cisplatin	cisplatin	NOUN
gra-1881	37	5	chemotherapy	chemotherapy	NOUN
gra-1881	37	6	can	can	AUX
gra-1881	37	7	provide	provide	VERB
gra-1881	37	8	good	good	ADJ
gra-1881	37	9	alternative	alternative	NOUN
gra-1881	37	10	to	to	ADP
gra-1881	37	11	3	3	NUM
gra-1881	37	12	weekly	weekly	ADJ
gra-1881	37	13	cisplatin	cisplatin	NOUN
gra-1881	37	14	chemotherapy	chemotherapy	NOUN
gra-1881	37	15	with	with	ADP
gra-1881	37	16	lesser	less	ADJ
gra-1881	37	17	toxicity	toxicity	NOUN
gra-1881	37	18	.	.	PUNCT
gra-1881	38	1	abstract	abstract	ADJ
gra-1881	38	2	keywords	keyword	NOUN
gra-1881	38	3	:	:	PUNCT
gra-1881	38	4	head	head	NOUN
gra-1881	38	5	and	and	CCONJ
gra-1881	38	6	neck	neck	NOUN
gra-1881	38	7	cancer	cancer	NOUN
gra-1881	38	8	,	,	PUNCT
gra-1881	38	9	radiotherapy	radiotherapy	NOUN
gra-1881	38	10	,	,	PUNCT
gra-1881	38	11	concurrent	concurrent	ADJ
gra-1881	38	12	chemotherapy	chemotherapy	NOUN
gra-1881	38	13	volume-9	volume-9	NUM
gra-1881	38	14	,	,	PUNCT
gra-1881	38	15	issue-2	issue-2	PROPN
gra-1881	38	16	,	,	PUNCT
gra-1881	38	17	february-2020	february-2020	VERB
gra-1881	38	18	•	•	NUM
gra-1881	38	19	print	print	NOUN
gra-1881	38	20	issn	issn	PROPN
gra-1881	38	21	no	no	NOUN
gra-1881	38	22	.	.	PROPN
gra-1881	38	23	2277	2277	NUM
gra-1881	38	24	8160	8160	NUM
gra-1881	38	25	•	•	NOUN
gra-1881	38	26	doi	doi	NOUN
gra-1881	38	27	:	:	PUNCT
gra-1881	38	28	10.36106	10.36106	NUM
gra-1881	38	29	/	/	SYM
gra-1881	38	30	gjra	gjra	PROPN
gra-1881	38	31	dr	dr	PROPN
gra-1881	38	32	.	.	PROPN
gra-1881	38	33	ayush	ayush	PROPN
gra-1881	38	34	naik	naik	PROPN
gra-1881	38	35	*	*	PROPN
gra-1881	38	36	department	department	PROPN
gra-1881	38	37	of	of	ADP
gra-1881	38	38	radiation	radiation	NOUN
gra-1881	38	39	oncology	oncology	NOUN
gra-1881	38	40	,	,	PUNCT
gra-1881	38	41	government	government	NOUN
gra-1881	38	42	cancer	cancer	NOUN
gra-1881	38	43	hospital	hospital	NOUN
gra-1881	38	44	,	,	PUNCT
gra-1881	38	45	mgm	mgm	PROPN
gra-1881	38	46	medical	medical	PROPN
gra-1881	38	47	college	college	PROPN
gra-1881	38	48	,	,	PUNCT
gra-1881	38	49	indore-452001	indore-452001	NOUN
gra-1881	38	50	*	*	PUNCT
gra-1881	38	51	corresponding	correspond	VERB
gra-1881	38	52	author	author	NOUN
gra-1881	38	53	56	56	NUM
gra-1881	38	54	x	x	NOUN
gra-1881	38	55	gjra	gjra	ADJ
gra-1881	38	56	global	global	ADJ
gra-1881	38	57	journal	journal	PROPN
gra-1881	38	58	for	for	ADP
gra-1881	38	59	research	research	NOUN
gra-1881	38	60	analysis	analysis	NOUN
gra-1881	38	61	growth	growth	NOUN
gra-1881	38	62	of	of	ADP
gra-1881	38	63	other	other	ADJ
gra-1881	38	64	lesions	lesion	NOUN
gra-1881	38	65	or	or	CCONJ
gra-1881	38	66	appearance	appearance	NOUN
gra-1881	38	67	of	of	ADP
gra-1881	38	68	new	new	ADJ
gra-1881	38	69	lesions	lesion	NOUN
gra-1881	38	70	.	.	PUNCT
gra-1881	39	1	stable	stable	ADJ
gra-1881	39	2	diseases	disease	NOUN
gra-1881	39	3	(	(	PUNCT
gra-1881	39	4	sd)was	sd)was	AUX
gra-1881	39	5	dened	dene	VERB
gra-1881	39	6	as	as	ADP
gra-1881	39	7	reduction	reduction	NOUN
gra-1881	39	8	in	in	ADP
gra-1881	39	9	lesion	lesion	NOUN
gra-1881	39	10	by	by	ADP
gra-1881	39	11	less	less	ADJ
gra-1881	39	12	than	than	ADP
gra-1881	39	13	50	50	NUM
gra-1881	39	14	%	%	NOUN
gra-1881	39	15	,	,	PUNCT
gra-1881	39	16	or	or	CCONJ
gra-1881	39	17	increase	increase	VERB
gra-1881	39	18	by	by	ADP
gra-1881	39	19	less	less	ADJ
gra-1881	39	20	than	than	ADP
gra-1881	39	21	25	25	NUM
gra-1881	39	22	%	%	NOUN
gra-1881	39	23	.	.	PUNCT
gra-1881	40	1	progressive	progressive	ADJ
gra-1881	40	2	disease(pd	disease(pd	NOUN
gra-1881	40	3	)	)	PUNCT
gra-1881	40	4	was	be	AUX
gra-1881	40	5	dened	dene	VERB
gra-1881	40	6	as	as	ADP
gra-1881	40	7	an	an	DET
gra-1881	40	8	increase	increase	NOUN
gra-1881	40	9	by	by	ADP
gra-1881	40	10	at	at	ADV
gra-1881	40	11	least	least	ADV
gra-1881	40	12	25	25	NUM
gra-1881	40	13	%	%	NOUN
gra-1881	40	14	of	of	ADP
gra-1881	40	15	tumor	tumor	NOUN
gra-1881	40	16	lesions	lesion	NOUN
gra-1881	40	17	or	or	CCONJ
gra-1881	40	18	appearance	appearance	NOUN
gra-1881	40	19	of	of	ADP
gra-1881	40	20	new	new	ADJ
gra-1881	40	21	lesions	lesion	NOUN
gra-1881	40	22	.	.	PUNCT
gra-1881	41	1	evaluation	evaluation	NOUN
gra-1881	41	2	of	of	ADP
gra-1881	41	3	toxicity	toxicity	NOUN
gra-1881	41	4	toxicities	toxicity	NOUN
gra-1881	41	5	were	be	AUX
gra-1881	41	6	evaluated	evaluate	VERB
gra-1881	41	7	by	by	ADP
gra-1881	41	8	history	history	NOUN
gra-1881	41	9	,	,	PUNCT
gra-1881	41	10	physical	physical	ADJ
gra-1881	41	11	examination	examination	NOUN
gra-1881	41	12	and	and	CCONJ
gra-1881	41	13	laboratory	laboratory	NOUN
gra-1881	41	14	tests	test	NOUN
gra-1881	41	15	.	.	PUNCT
gra-1881	42	1	the	the	DET
gra-1881	42	2	grading	grade	VERB
gra-1881	42	3	system	system	NOUN
gra-1881	42	4	was	be	AUX
gra-1881	42	5	based	base	VERB
gra-1881	42	6	on	on	ADP
gra-1881	42	7	the	the	DET
gra-1881	42	8	radiation	radiation	NOUN
gra-1881	42	9	therapy	therapy	NOUN
gra-1881	42	10	oncology	oncology	NOUN
gra-1881	42	11	group	group	NOUN
gra-1881	42	12	(	(	PUNCT
gra-1881	42	13	rtog	rtog	NOUN
gra-1881	42	14	)	)	PUNCT
gra-1881	42	15	acute	acute	ADJ
gra-1881	42	16	radiation	radiation	NOUN
gra-1881	42	17	morbidity	morbidity	NOUN
gra-1881	42	18	scoring	score	VERB
gra-1881	42	19	criteria.and	criteria.and	X
gra-1881	42	20	ctcae	ctcae	NOUN
gra-1881	42	21	v.4	v.4	NOUN
gra-1881	42	22	.	.	PUNCT
gra-1881	43	1	statistical	statistical	ADJ
gra-1881	43	2	analysis	analysis	NOUN
gra-1881	43	3	for	for	ADP
gra-1881	43	4	statistical	statistical	ADJ
gra-1881	43	5	analysis	analysis	NOUN
gra-1881	43	6	student	student	NOUN
gra-1881	43	7	unpaired	unpaire	VERB
gra-1881	43	8	t	t	PROPN
gra-1881	43	9	test	test	NOUN
gra-1881	43	10	was	be	AUX
gra-1881	43	11	applied	apply	VERB
gra-1881	43	12	and	and	CCONJ
gra-1881	43	13	p	p	NOUN
gra-1881	43	14	value	value	NOUN
gra-1881	43	15	was	be	AUX
gra-1881	43	16	calculated	calculate	VERB
gra-1881	43	17	between	between	ADP
gra-1881	43	18	two	two	NUM
gra-1881	43	19	arms.the	arms.the	DET
gra-1881	43	20	statistics	statistic	NOUN
gra-1881	43	21	was	be	AUX
gra-1881	43	22	calculated	calculate	VERB
gra-1881	43	23	using	use	VERB
gra-1881	43	24	mini	mini	ADJ
gra-1881	43	25	tab	tab	NOUN
gra-1881	43	26	version	version	NOUN
gra-1881	43	27	17.0	17.0	NUM
gra-1881	43	28	.	.	PUNCT
gra-1881	44	1	observations	observation	NOUN
gra-1881	44	2	and	and	CCONJ
gra-1881	44	3	results	result	NOUN
gra-1881	44	4	:	:	PUNCT
gra-1881	44	5	according	accord	VERB
gra-1881	44	6	to	to	ADP
gra-1881	44	7	staging	stage	VERB
gra-1881	44	8	in	in	ADP
gra-1881	44	9	group	group	PROPN
gra-1881	44	10	a	a	NOUN
gra-1881	44	11	,	,	PUNCT
gra-1881	44	12	stage	stage	NOUN
gra-1881	44	13	iii	iii	NUM
gra-1881	44	14	patients	patient	NOUN
gra-1881	44	15	were	be	AUX
gra-1881	44	16	8	8	NUM
gra-1881	44	17	(	(	PUNCT
gra-1881	44	18	32	32	NUM
gra-1881	44	19	%	%	NOUN
gra-1881	44	20	)	)	PUNCT
gra-1881	44	21	,	,	PUNCT
gra-1881	44	22	with	with	ADP
gra-1881	44	23	stage	stage	NOUN
gra-1881	44	24	iv	iv	NUM
gra-1881	44	25	a	a	DET
gra-1881	44	26	were	be	AUX
gra-1881	44	27	15	15	NUM
gra-1881	44	28	(	(	PUNCT
gra-1881	44	29	60	60	NUM
gra-1881	44	30	%	%	NOUN
gra-1881	44	31	)	)	PUNCT
gra-1881	44	32	and	and	CCONJ
gra-1881	44	33	with	with	ADP
gra-1881	44	34	stage	stage	NOUN
gra-1881	44	35	iv	iv	NUM
gra-1881	44	36	b	b	NOUN
gra-1881	44	37	were	be	AUX
gra-1881	44	38	2(8	2(8	NUM
gra-1881	44	39	%	%	NOUN
gra-1881	44	40	)	)	PUNCT
gra-1881	44	41	.	.	PUNCT
gra-1881	45	1	in	in	ADP
gra-1881	45	2	group	group	PROPN
gra-1881	45	3	b	b	PROPN
gra-1881	45	4	,	,	PUNCT
gra-1881	45	5	stage	stage	NOUN
gra-1881	45	6	iii	iii	NUM
gra-1881	45	7	patients	patient	NOUN
gra-1881	45	8	were	be	AUX
gra-1881	45	9	7	7	NUM
gra-1881	45	10	(	(	PUNCT
gra-1881	45	11	28	28	NUM
gra-1881	45	12	%	%	NOUN
gra-1881	45	13	)	)	PUNCT
gra-1881	45	14	,	,	PUNCT
gra-1881	45	15	stage	stage	NOUN
gra-1881	45	16	iv	iv	VERB
gra-1881	45	17	a	a	DET
gra-1881	45	18	patients	patient	NOUN
gra-1881	45	19	were	be	AUX
gra-1881	45	20	15	15	NUM
gra-1881	45	21	(	(	PUNCT
gra-1881	45	22	60	60	NUM
gra-1881	45	23	%	%	NOUN
gra-1881	45	24	)	)	PUNCT
gra-1881	45	25	and	and	CCONJ
gra-1881	45	26	stage	stage	NOUN
gra-1881	45	27	iv	iv	NUM
gra-1881	45	28	b	b	NOUN
gra-1881	45	29	were	be	AUX
gra-1881	45	30	3	3	NUM
gra-1881	45	31	(	(	PUNCT
gra-1881	45	32	12	12	NUM
gra-1881	45	33	%	%	NOUN
gra-1881	45	34	)	)	PUNCT
gra-1881	45	35	.	.	PUNCT
gra-1881	46	1	table	table	NOUN
gra-1881	46	2	1	1	NUM
gra-1881	46	3	shows	show	VERB
gra-1881	46	4	the	the	DET
gra-1881	46	5	site	site	NOUN
gra-1881	46	6	wise	wise	ADJ
gra-1881	46	7	distribution	distribution	NOUN
gra-1881	46	8	of	of	ADP
gra-1881	46	9	patients	patient	NOUN
gra-1881	46	10	in	in	ADP
gra-1881	46	11	both	both	CCONJ
gra-1881	46	12	the	the	DET
gra-1881	46	13	arms	arm	NOUN
gra-1881	46	14	.	.	PUNCT
gra-1881	46	15	table	table	NOUN
gra-1881	46	16	1	1	NUM
gra-1881	46	17	:	:	PUNCT
gra-1881	46	18	distribution	distribution	NOUN
gra-1881	46	19	of	of	ADP
gra-1881	46	20	patients	patient	NOUN
gra-1881	46	21	according	accord	VERB
gra-1881	46	22	to	to	ADP
gra-1881	46	23	site	site	NOUN
gra-1881	46	24	of	of	ADP
gra-1881	46	25	disease	disease	NOUN
gra-1881	46	26	.	.	PUNCT
gra-1881	47	1	toxicity	toxicity	NOUN
gra-1881	47	2	evaluation	evaluation	NOUN
gra-1881	47	3	:	:	PUNCT
gra-1881	47	4	details	detail	NOUN
gra-1881	47	5	given	give	VERB
gra-1881	47	6	table	table	NOUN
gra-1881	47	7	2	2	NUM
gra-1881	47	8	showing	show	VERB
gra-1881	47	9	different	different	ADJ
gra-1881	47	10	toxicities	toxicity	NOUN
gra-1881	47	11	observed	observe	VERB
gra-1881	47	12	response	response	NOUN
gra-1881	47	13	evaluation	evaluation	NOUN
gra-1881	47	14	:	:	PUNCT
gra-1881	47	15	complete	complete	ADJ
gra-1881	47	16	response	response	NOUN
gra-1881	47	17	was	be	AUX
gra-1881	47	18	achieved	achieve	VERB
gra-1881	47	19	in	in	ADP
gra-1881	47	20	14	14	NUM
gra-1881	47	21	(	(	PUNCT
gra-1881	47	22	56	56	NUM
gra-1881	47	23	%	%	NOUN
gra-1881	47	24	)	)	PUNCT
gra-1881	47	25	patients	patient	NOUN
gra-1881	47	26	in	in	ADP
gra-1881	47	27	group	group	PROPN
gra-1881	47	28	a	a	PROPN
gra-1881	47	29	and	and	CCONJ
gra-1881	47	30	12	12	NUM
gra-1881	47	31	(	(	PUNCT
gra-1881	47	32	54.55	54.55	NUM
gra-1881	47	33	%	%	NOUN
gra-1881	47	34	)	)	PUNCT
gra-1881	47	35	patients	patient	NOUN
gra-1881	47	36	in	in	ADP
gra-1881	47	37	group	group	PROPN
gra-1881	47	38	b	b	PROPN
gra-1881	47	39	,	,	PUNCT
gra-1881	47	40	while	while	SCONJ
gra-1881	47	41	progressive	progressive	ADJ
gra-1881	47	42	disease	disease	NOUN
gra-1881	47	43	was	be	AUX
gra-1881	47	44	seen	see	VERB
gra-1881	47	45	in	in	ADP
gra-1881	47	46	2	2	NUM
gra-1881	47	47	(	(	PUNCT
gra-1881	47	48	8	8	NUM
gra-1881	47	49	%	%	NOUN
gra-1881	47	50	)	)	PUNCT
gra-1881	47	51	patients	patient	NOUN
gra-1881	47	52	in	in	ADP
gra-1881	47	53	group	group	PROPN
gra-1881	47	54	a	a	PROPN
gra-1881	47	55	and	and	CCONJ
gra-1881	47	56	2	2	NUM
gra-1881	47	57	(	(	PUNCT
gra-1881	47	58	9.09	9.09	NUM
gra-1881	47	59	%	%	NOUN
gra-1881	47	60	)	)	PUNCT
gra-1881	47	61	patients	patient	NOUN
gra-1881	47	62	in	in	ADP
gra-1881	47	63	group	group	PROPN
gra-1881	47	64	b.	b.	PROPN
gra-1881	47	65	in	in	ADP
gra-1881	47	66	group	group	PROPN
gra-1881	47	67	a	a	PROPN
gra-1881	47	68	,	,	PUNCT
gra-1881	47	69	3	3	NUM
gra-1881	47	70	(	(	PUNCT
gra-1881	47	71	12	12	NUM
gra-1881	47	72	%	%	NOUN
gra-1881	47	73	)	)	PUNCT
gra-1881	47	74	patients	patient	NOUN
gra-1881	47	75	had	have	VERB
gra-1881	47	76	stable	stable	ADJ
gra-1881	47	77	disease	disease	NOUN
gra-1881	47	78	and	and	CCONJ
gra-1881	47	79	6	6	NUM
gra-1881	47	80	(	(	PUNCT
gra-1881	47	81	24	24	NUM
gra-1881	47	82	%	%	NOUN
gra-1881	47	83	)	)	PUNCT
gra-1881	47	84	patients	patient	NOUN
gra-1881	47	85	had	have	VERB
gra-1881	47	86	partial	partial	ADJ
gra-1881	47	87	response	response	NOUN
gra-1881	47	88	while	while	SCONJ
gra-1881	47	89	1	1	NUM
gra-1881	47	90	(	(	PUNCT
gra-1881	47	91	4.55	4.55	NUM
gra-1881	47	92	%	%	NOUN
gra-1881	47	93	)	)	PUNCT
gra-1881	47	94	patient	patient	NOUN
gra-1881	47	95	in	in	ADP
gra-1881	47	96	group	group	PROPN
gra-1881	47	97	b	b	PROPN
gra-1881	47	98	had	have	VERB
gra-1881	47	99	stable	stable	ADJ
gra-1881	47	100	disease	disease	NOUN
gra-1881	47	101	and	and	CCONJ
gra-1881	47	102	7	7	NUM
gra-1881	47	103	(	(	PUNCT
gra-1881	47	104	31.82	31.82	NUM
gra-1881	47	105	%	%	NOUN
gra-1881	47	106	)	)	PUNCT
gra-1881	47	107	patients	patient	NOUN
gra-1881	47	108	had	have	VERB
gra-1881	47	109	partial	partial	ADJ
gra-1881	47	110	response	response	NOUN
gra-1881	47	111	with	with	ADP
gra-1881	47	112	no	no	DET
gra-1881	47	113	signicant	signicant	ADJ
gra-1881	47	114	difference	difference	NOUN
gra-1881	47	115	between	between	ADP
gra-1881	47	116	both	both	DET
gra-1881	47	117	groups	group	NOUN
gra-1881	47	118	.	.	PUNCT
gra-1881	48	1	discussion	discussion	NOUN
gra-1881	48	2	:	:	PUNCT
gra-1881	48	3	historically	historically	ADV
gra-1881	48	4	cisplatin	cisplatin	NOUN
gra-1881	48	5	100	100	NUM
gra-1881	48	6	mg	mg	NUM
gra-1881	48	7	/	/	SYM
gra-1881	48	8	m2	m2	PROPN
gra-1881	48	9	once	once	ADV
gra-1881	48	10	in	in	ADP
gra-1881	48	11	every	every	DET
gra-1881	48	12	3	3	NUM
gra-1881	48	13	weeks	week	NOUN
gra-1881	48	14	along	along	ADP
gra-1881	48	15	with	with	ADP
gra-1881	48	16	radiotherapy	radiotherapy	NOUN
gra-1881	48	17	was	be	AUX
gra-1881	48	18	recommended	recommend	VERB
gra-1881	48	19	as	as	ADP
gra-1881	48	20	standard	standard	ADJ
gra-1881	48	21	regimen	regiman	NOUN
gra-1881	48	22	for	for	ADP
gra-1881	48	23	adjuvant	adjuvant	ADJ
gra-1881	48	24	treatment	treatment	NOUN
gra-1881	48	25	in	in	ADP
gra-1881	48	26	hnscc	hnscc	NOUN
gra-1881	48	27	.	.	PUNCT
gra-1881	49	1	however	however	ADV
gra-1881	49	2	it	it	PRON
gra-1881	49	3	was	be	AUX
gra-1881	49	4	seen	see	VERB
gra-1881	49	5	that	that	SCONJ
gra-1881	49	6	schedules	schedule	NOUN
gra-1881	49	7	that	that	PRON
gra-1881	49	8	deliver	deliver	VERB
gra-1881	49	9	cisplatin	cisplatin	NOUN
gra-1881	49	10	in	in	ADP
gra-1881	49	11	smaller	small	ADJ
gra-1881	49	12	doses	dose	NOUN
gra-1881	49	13	on	on	ADP
gra-1881	49	14	a	a	DET
gra-1881	49	15	more	more	ADV
gra-1881	49	16	frequent	frequent	ADJ
gra-1881	49	17	basis	basis	NOUN
gra-1881	49	18	may	may	AUX
gra-1881	49	19	be	be	AUX
gra-1881	49	20	preferable	preferable	ADJ
gra-1881	49	21	to	to	ADP
gra-1881	49	22	high	high	ADJ
gra-1881	49	23	dose	dose	VERB
gra-1881	49	24	bolus	bolus	PROPN
gra-1881	49	25	administration	administration	NOUN
gra-1881	49	26	as	as	SCONJ
gra-1881	49	27	more	more	ADV
gra-1881	49	28	frequent	frequent	ADJ
gra-1881	49	29	administration	administration	NOUN
gra-1881	49	30	could	could	AUX
gra-1881	49	31	provide	provide	VERB
gra-1881	49	32	radio	radio	NOUN
gra-1881	49	33	sensitizing	sensitize	VERB
gra-1881	49	34	chemotherapy	chemotherapy	NOUN
gra-1881	49	35	and	and	CCONJ
gra-1881	49	36	small	small	ADJ
gra-1881	49	37	individual	individual	ADJ
gra-1881	49	38	doses	dose	NOUN
gra-1881	49	39	of	of	ADP
gra-1881	49	40	cisplatin	cisplatin	NOUN
gra-1881	49	41	may	may	AUX
gra-1881	49	42	lead	lead	VERB
gra-1881	49	43	to	to	ADP
gra-1881	49	44	less	less	ADJ
gra-1881	49	45	chemotherapy	chemotherapy	NOUN
gra-1881	49	46	induced	induce	VERB
gra-1881	49	47	morbidity	morbidity	NOUN
gra-1881	49	48	without	without	ADP
gra-1881	49	49	compromising	compromise	VERB
gra-1881	49	50	efcacy	efcacy	NOUN
gra-1881	49	51	.	.	PUNCT
gra-1881	50	1	in	in	ADP
gra-1881	50	2	our	our	PRON
gra-1881	50	3	study	study	NOUN
gra-1881	50	4	the	the	DET
gra-1881	50	5	baseline	baseline	PROPN
gra-1881	50	6	characteristics	characteristic	NOUN
gra-1881	50	7	of	of	ADP
gra-1881	50	8	patients	patient	NOUN
gra-1881	50	9	were	be	AUX
gra-1881	50	10	similar	similar	ADJ
gra-1881	50	11	and	and	CCONJ
gra-1881	50	12	no	no	DET
gra-1881	50	13	signicant	signicant	ADJ
gra-1881	50	14	difference	difference	NOUN
gra-1881	50	15	was	be	AUX
gra-1881	50	16	seen	see	VERB
gra-1881	50	17	between	between	ADP
gra-1881	50	18	group	group	NOUN
gra-1881	50	19	a	a	PROPN
gra-1881	50	20	and	and	CCONJ
gra-1881	50	21	group	group	PROPN
gra-1881	50	22	b	b	PROPN
gra-1881	50	23	with	with	ADP
gra-1881	50	24	respect	respect	NOUN
gra-1881	50	25	to	to	ADP
gra-1881	50	26	age	age	NOUN
gra-1881	50	27	,	,	PUNCT
gra-1881	50	28	sex	sex	NOUN
gra-1881	50	29	,	,	PUNCT
gra-1881	50	30	performance	performance	NOUN
gra-1881	50	31	status	status	NOUN
gra-1881	50	32	,	,	PUNCT
gra-1881	50	33	grade	grade	NOUN
gra-1881	50	34	and	and	CCONJ
gra-1881	50	35	stage	stage	NOUN
gra-1881	50	36	.	.	PUNCT
gra-1881	51	1	according	accord	VERB
gra-1881	51	2	to	to	ADP
gra-1881	51	3	ajcc	ajcc	NOUN
gra-1881	51	4	staging	stage	VERB
gra-1881	51	5	in	in	ADP
gra-1881	51	6	our	our	PRON
gra-1881	51	7	study	study	NOUN
gra-1881	51	8	majority	majority	NOUN
gra-1881	51	9	of	of	ADP
gra-1881	51	10	patients	patient	NOUN
gra-1881	51	11	had	have	VERB
gra-1881	51	12	stage	stage	NOUN
gra-1881	51	13	iva	iva	PROPN
gra-1881	51	14	disease	disease	NOUN
gra-1881	51	15	,	,	PUNCT
gra-1881	51	16	constituting	constitute	VERB
gra-1881	51	17	60	60	NUM
gra-1881	51	18	%	%	NOUN
gra-1881	51	19	in	in	ADP
gra-1881	51	20	both	both	DET
gra-1881	51	21	groups	group	NOUN
gra-1881	51	22	which	which	PRON
gra-1881	51	23	[	[	X
gra-1881	51	24	6]was	6]wa	VERB
gra-1881	51	25	similar	similar	ADJ
gra-1881	51	26	to	to	ADP
gra-1881	51	27	what	what	PRON
gra-1881	51	28	was	be	AUX
gra-1881	51	29	seen	see	VERB
gra-1881	51	30	in	in	ADP
gra-1881	51	31	study	study	NOUN
gra-1881	51	32	by	by	ADP
gra-1881	51	33	ahmed	ahmed	PROPN
gra-1881	51	34	el	el	PROPN
gra-1881	51	35	-	-	NOUN
gra-1881	51	36	azony	azony	NOUN
gra-1881	51	37	in	in	ADP
gra-1881	51	38	which	which	PRON
gra-1881	51	39	45	45	NUM
gra-1881	51	40	%	%	NOUN
gra-1881	51	41	of	of	ADP
gra-1881	51	42	patients	patient	NOUN
gra-1881	51	43	had	have	VERB
gra-1881	51	44	stage	stage	NOUN
gra-1881	51	45	iva	iva	PROPN
gra-1881	51	46	disease	disease	NOUN
gra-1881	51	47	in	in	ADP
gra-1881	51	48	both	both	DET
gra-1881	51	49	groups	group	NOUN
gra-1881	51	50	.	.	PUNCT
gra-1881	52	1	with	with	ADP
gra-1881	52	2	regards	regard	NOUN
gra-1881	52	3	to	to	ADP
gra-1881	52	4	response	response	NOUN
gra-1881	52	5	to	to	ADP
gra-1881	52	6	treatment	treatment	NOUN
gra-1881	52	7	in	in	ADP
gra-1881	52	8	our	our	PRON
gra-1881	52	9	study	study	NOUN
gra-1881	52	10	cr	cr	NOUN
gra-1881	52	11	was	be	AUX
gra-1881	52	12	seen	see	VERB
gra-1881	52	13	in	in	ADP
gra-1881	52	14	56	56	NUM
gra-1881	52	15	%	%	NOUN
gra-1881	52	16	of	of	ADP
gra-1881	52	17	patients	patient	NOUN
gra-1881	52	18	in	in	ADP
gra-1881	52	19	group	group	PROPN
gra-1881	52	20	a	a	PROPN
gra-1881	52	21	and	and	CCONJ
gra-1881	52	22	54.5	54.5	NUM
gra-1881	52	23	%	%	NOUN
gra-1881	52	24	of	of	ADP
gra-1881	52	25	patients	patient	NOUN
gra-1881	52	26	in	in	ADP
gra-1881	52	27	group	group	PROPN
gra-1881	52	28	b	b	PROPN
gra-1881	52	29	while	while	SCONJ
gra-1881	52	30	3	3	NUM
gra-1881	52	31	(	(	PUNCT
gra-1881	52	32	12	12	NUM
gra-1881	52	33	%	%	NOUN
gra-1881	52	34	)	)	PUNCT
gra-1881	52	35	patients	patient	NOUN
gra-1881	52	36	had	have	VERB
gra-1881	52	37	stable	stable	ADJ
gra-1881	52	38	disease	disease	NOUN
gra-1881	52	39	and	and	CCONJ
gra-1881	52	40	6	6	NUM
gra-1881	52	41	(	(	PUNCT
gra-1881	52	42	24	24	NUM
gra-1881	52	43	%	%	NOUN
gra-1881	52	44	)	)	PUNCT
gra-1881	53	1	patients	patient	NOUN
gra-1881	53	2	had	have	VERB
gra-1881	53	3	partial	partial	ADJ
gra-1881	53	4	response	response	NOUN
gra-1881	53	5	in	in	ADP
gra-1881	53	6	group	group	NOUN
gra-1881	53	7	a	a	DET
gra-1881	53	8	while	while	NOUN
gra-1881	53	9	1	1	NUM
gra-1881	53	10	(	(	PUNCT
gra-1881	53	11	4.55	4.55	NUM
gra-1881	53	12	%	%	NOUN
gra-1881	53	13	)	)	PUNCT
gra-1881	53	14	patient	patient	NOUN
gra-1881	53	15	in	in	ADP
gra-1881	53	16	group	group	PROPN
gra-1881	53	17	b	b	PROPN
gra-1881	53	18	had	have	VERB
gra-1881	53	19	stable	stable	ADJ
gra-1881	53	20	disease	disease	NOUN
gra-1881	53	21	and	and	CCONJ
gra-1881	53	22	7	7	NUM
gra-1881	53	23	(	(	PUNCT
gra-1881	53	24	31.82	31.82	NUM
gra-1881	53	25	%	%	NOUN
gra-1881	53	26	)	)	PUNCT
gra-1881	54	1	patients	patient	NOUN
gra-1881	54	2	had	have	VERB
gra-1881	54	3	partial	partial	ADJ
gra-1881	54	4	response	response	NOUN
gra-1881	54	5	with	with	ADP
gra-1881	54	6	no	no	DET
gra-1881	54	7	signicant	signicant	ADJ
gra-1881	54	8	difference	difference	NOUN
gra-1881	54	9	between	between	ADP
gra-1881	54	10	[	[	X
gra-1881	54	11	6]both	6]both	NUM
gra-1881	54	12	groups	group	NOUN
gra-1881	54	13	.	.	PUNCT
gra-1881	55	1	in	in	ADP
gra-1881	55	2	similar	similar	ADJ
gra-1881	55	3	study	study	NOUN
gra-1881	55	4	by	by	ADP
gra-1881	55	5	ahmed	ahmed	PROPN
gra-1881	55	6	elazony	elazony	PROPN
gra-1881	55	7	,	,	PUNCT
gra-1881	55	8	cr	cr	PROPN
gra-1881	55	9	was	be	AUX
gra-1881	55	10	achieved	achieve	VERB
gra-1881	55	11	in	in	ADP
gra-1881	55	12	10	10	NUM
gra-1881	55	13	(	(	PUNCT
gra-1881	55	14	50	50	NUM
gra-1881	55	15	%	%	NOUN
gra-1881	55	16	)	)	PUNCT
gra-1881	55	17	in	in	ADP
gra-1881	55	18	3	3	NUM
gra-1881	55	19	weekly	weekly	ADJ
gra-1881	55	20	group	group	NOUN
gra-1881	55	21	and	and	CCONJ
gra-1881	55	22	9	9	NUM
gra-1881	55	23	(	(	PUNCT
gra-1881	55	24	45	45	NUM
gra-1881	55	25	%	%	NOUN
gra-1881	55	26	)	)	PUNCT
gra-1881	55	27	patients	patient	NOUN
gra-1881	55	28	in	in	ADP
gra-1881	55	29	weekly	weekly	ADJ
gra-1881	55	30	group	group	NOUN
gra-1881	55	31	,	,	PUNCT
gra-1881	55	32	while	while	SCONJ
gra-1881	55	33	pr	pr	NOUN
gra-1881	55	34	was	be	AUX
gra-1881	55	35	achieved	achieve	VERB
gra-1881	55	36	in	in	ADP
gra-1881	55	37	7(35	7(35	NUM
gra-1881	55	38	%	%	NOUN
gra-1881	55	39	)	)	PUNCT
gra-1881	55	40	patients	patient	NOUN
gra-1881	55	41	in	in	ADP
gra-1881	55	42	both	both	DET
gra-1881	55	43	groups	group	NOUN
gra-1881	55	44	.	.	PUNCT
gra-1881	56	1	3	3	NUM
gra-1881	56	2	(	(	PUNCT
gra-1881	56	3	15	15	NUM
gra-1881	56	4	%	%	NOUN
gra-1881	56	5	)	)	PUNCT
gra-1881	56	6	patients	patient	NOUN
gra-1881	56	7	in	in	ADP
gra-1881	56	8	group	group	PROPN
gra-1881	56	9	a	a	PRON
gra-1881	56	10	had	have	VERB
gra-1881	56	11	no	no	DET
gra-1881	56	12	response	response	NOUN
gra-1881	56	13	of	of	ADP
gra-1881	56	14	whom	whom	PRON
gra-1881	56	15	2	2	NUM
gra-1881	56	16	patients	patient	NOUN
gra-1881	56	17	had	have	VERB
gra-1881	56	18	sd	sd	NOUN
gra-1881	56	19	and	and	CCONJ
gra-1881	56	20	1	1	NUM
gra-1881	56	21	patient	patient	NOUN
gra-1881	56	22	had	have	VERB
gra-1881	56	23	pd	pd	NOUN
gra-1881	56	24	while	while	SCONJ
gra-1881	56	25	4	4	NUM
gra-1881	56	26	(	(	PUNCT
gra-1881	56	27	20	20	NUM
gra-1881	56	28	%	%	NOUN
gra-1881	56	29	)	)	PUNCT
gra-1881	56	30	patients	patient	NOUN
gra-1881	56	31	in	in	ADP
gra-1881	56	32	group	group	PROPN
gra-1881	56	33	b	b	PROPN
gra-1881	56	34	had	have	VERB
gra-1881	56	35	no	no	DET
gra-1881	56	36	response	response	NOUN
gra-1881	56	37	of	of	ADP
gra-1881	56	38	whom	whom	PRON
gra-1881	56	39	3	3	NUM
gra-1881	56	40	(	(	PUNCT
gra-1881	56	41	15	15	NUM
gra-1881	56	42	%	%	NOUN
gra-1881	56	43	)	)	PUNCT
gra-1881	56	44	had	have	VERB
gra-1881	56	45	sd	sd	NOUN
gra-1881	56	46	and	and	CCONJ
gra-1881	56	47	1	1	NUM
gra-1881	56	48	(	(	PUNCT
gra-1881	56	49	5	5	NUM
gra-1881	56	50	%	%	NOUN
gra-1881	56	51	)	)	PUNCT
gra-1881	56	52	patient	patient	NOUN
gra-1881	56	53	had	have	VERB
gra-1881	56	54	pd	pd	PROPN
gra-1881	56	55	.	.	PROPN
gra-1881	56	56	similar	similar	ADJ
gra-1881	56	57	to	to	ADP
gra-1881	56	58	our	our	PRON
gra-1881	56	59	study	study	NOUN
gra-1881	56	60	no	no	DET
gra-1881	56	61	statistically	statistically	ADV
gra-1881	56	62	signicant	signicant	ADJ
gra-1881	56	63	difference	difference	NOUN
gra-1881	56	64	was	be	AUX
gra-1881	56	65	seen	see	VERB
gra-1881	56	66	in	in	ADP
gra-1881	56	67	both	both	DET
gra-1881	56	68	arms	arm	NOUN
gra-1881	56	69	and	and	CCONJ
gra-1881	56	70	comparison	comparison	NOUN
gra-1881	56	71	between	between	ADP
gra-1881	56	72	two	two	NUM
gra-1881	56	73	modalities	modality	NOUN
gra-1881	56	74	resulted	result	VERB
gra-1881	56	75	in	in	ADP
gra-1881	56	76	statistically	statistically	ADV
gra-1881	56	77	similar	similar	ADJ
gra-1881	56	78	response	response	NOUN
gra-1881	56	79	rates	rate	NOUN
gra-1881	56	80	and	and	CCONJ
gra-1881	56	81	adverse	adverse	ADJ
gra-1881	56	82	event	event	NOUN
gra-1881	56	83	prole	prole	PROPN
gra-1881	56	84	.	.	PUNCT
gra-1881	57	1	in	in	ADP
gra-1881	57	2	our	our	PRON
gra-1881	57	3	study	study	NOUN
gra-1881	57	4	no	no	DET
gra-1881	57	5	signicant	signicant	ADJ
gra-1881	57	6	difference	difference	NOUN
gra-1881	57	7	was	be	AUX
gra-1881	57	8	seen	see	VERB
gra-1881	57	9	in	in	ADP
gra-1881	57	10	terms	term	NOUN
gra-1881	57	11	of	of	ADP
gra-1881	57	12	all	all	DET
gra-1881	57	13	measured	measure	VERB
gra-1881	57	14	toxicities	toxicity	NOUN
gra-1881	57	15	but	but	CCONJ
gra-1881	57	16	hematological	hematological	ADJ
gra-1881	57	17	toxicities	toxicity	NOUN
gra-1881	57	18	were	be	AUX
gra-1881	57	19	higher	high	ADJ
gra-1881	57	20	in	in	ADP
gra-1881	57	21	group	group	PROPN
gra-1881	57	22	b.	b.	PROPN
gra-1881	57	23	regarding	regard	VERB
gra-1881	57	24	acute	acute	PROPN
gra-1881	57	25	mucositis	mucositis	PROPN
gra-1881	57	26	and	and	CCONJ
gra-1881	57	27	dermatitis	dermatitis	NOUN
gra-1881	57	28	,	,	PUNCT
gra-1881	57	29	most	most	ADJ
gra-1881	57	30	of	of	ADP
gra-1881	57	31	them	they	PRON
gra-1881	57	32	were	be	AUX
gra-1881	57	33	grade	grade	NOUN
gra-1881	57	34	1	1	NUM
gra-1881	57	35	and	and	CCONJ
gra-1881	57	36	2	2	NUM
gra-1881	57	37	and	and	CCONJ
gra-1881	57	38	were	be	AUX
gra-1881	57	39	taken	take	VERB
gra-1881	57	40	care	care	NOUN
gra-1881	57	41	of	of	ADP
gra-1881	57	42	on	on	ADP
gra-1881	57	43	outpatient	outpatient	NOUN
gra-1881	57	44	care	care	NOUN
gra-1881	57	45	basis	basis	NOUN
gra-1881	57	46	.	.	PUNCT
gra-1881	58	1	no	no	DET
gra-1881	58	2	signicant	signicant	ADJ
gra-1881	58	3	difference	difference	NOUN
gra-1881	58	4	was	be	AUX
gra-1881	58	5	seen	see	VERB
gra-1881	58	6	between	between	ADP
gra-1881	58	7	acute	acute	ADJ
gra-1881	58	8	toxicities	toxicity	NOUN
gra-1881	58	9	in	in	ADP
gra-1881	58	10	two	two	NUM
gra-1881	58	11	groups	group	NOUN
gra-1881	58	12	.	.	PUNCT
gra-1881	59	1	no	no	DET
gra-1881	59	2	grade	grade	NOUN
gra-1881	59	3	iv	iv	NUM
gra-1881	59	4	toxicities	toxicity	NOUN
gra-1881	59	5	were	be	AUX
gra-1881	59	6	seen	see	VERB
gra-1881	59	7	in	in	ADP
gra-1881	59	8	[	[	PUNCT
gra-1881	59	9	7]either	7]either	NUM
gra-1881	59	10	groups	group	NOUN
gra-1881	59	11	..	..	PUNCT
gra-1881	59	12	uygun	uygun	PROPN
gra-1881	59	13	et	et	PROPN
gra-1881	59	14	al	al	PROPN
gra-1881	59	15	,	,	PUNCT
gra-1881	59	16	showed	show	VERB
gra-1881	59	17	that	that	SCONJ
gra-1881	59	18	grade	grade	NOUN
gra-1881	59	19	3	3	NUM
gra-1881	59	20	-	-	SYM
gra-1881	59	21	4	4	NUM
gra-1881	59	22	toxic	toxic	ADJ
gra-1881	59	23	events	event	NOUN
gra-1881	59	24	were	be	AUX
gra-1881	59	25	53.3	53.3	NUM
gra-1881	59	26	%	%	NOUN
gra-1881	59	27	in	in	ADP
gra-1881	59	28	3	3	NUM
gra-1881	59	29	weekly	weekly	ADJ
gra-1881	59	30	and	and	CCONJ
gra-1881	59	31	40	40	NUM
gra-1881	59	32	%	%	NOUN
gra-1881	59	33	in	in	ADP
gra-1881	59	34	weekly	weekly	ADJ
gra-1881	59	35	cisplatin	cisplatin	NOUN
gra-1881	59	36	and	and	CCONJ
gra-1881	59	37	no	no	DET
gra-1881	59	38	statistical	statistical	ADJ
gra-1881	59	39	difference	difference	NOUN
gra-1881	59	40	was	be	AUX
gra-1881	59	41	seen	see	VERB
gra-1881	59	42	similar	similar	ADJ
gra-1881	59	43	to	to	ADP
gra-1881	59	44	our	our	PRON
gra-1881	59	45	study	study	NOUN
gra-1881	59	46	.	.	PUNCT
gra-1881	60	1	,	,	PUNCT
gra-1881	60	2	[	[	X
gra-1881	60	3	8]similiarly	8]similiarly	ADV
gra-1881	60	4	in	in	ADP
gra-1881	60	5	a	a	DET
gra-1881	60	6	study	study	NOUN
gra-1881	60	7	by	by	ADP
gra-1881	60	8	kose	kose	PROPN
gra-1881	60	9	et	et	PROPN
gra-1881	60	10	al	al	PROPN
gra-1881	60	11	showed	show	VERB
gra-1881	60	12	no	no	DET
gra-1881	60	13	difference	difference	NOUN
gra-1881	60	14	in	in	ADP
gra-1881	60	15	,	,	PUNCT
gra-1881	60	16	[	[	X
gra-1881	60	17	9]terms	9]term	NOUN
gra-1881	60	18	of	of	ADP
gra-1881	60	19	grade	grade	NOUN
gra-1881	60	20	3	3	NUM
gra-1881	60	21	-	-	SYM
gra-1881	60	22	4	4	NUM
gra-1881	60	23	mucositis.geeta	mucositis.geeta	NUM
gra-1881	60	24	et	et	NOUN
gra-1881	60	25	al	al	PROPN
gra-1881	60	26	showed	show	VERB
gra-1881	60	27	that	that	SCONJ
gra-1881	60	28	3	3	NUM
gra-1881	60	29	weekly	weekly	NOUN
gra-1881	60	30	was	be	AUX
gra-1881	60	31	less	less	ADV
gra-1881	60	32	toxic	toxic	ADJ
gra-1881	60	33	as	as	ADP
gra-1881	60	34	compared	compare	VERB
gra-1881	60	35	to	to	ADP
gra-1881	60	36	weekly	weekly	ADJ
gra-1881	60	37	cisplatin	cisplatin	NOUN
gra-1881	60	38	.	.	PUNCT
gra-1881	61	1	less	less	ADJ
gra-1881	61	2	grade	grade	NOUN
gra-1881	61	3	iii	iii	NOUN
gra-1881	61	4	toxicity	toxicity	NOUN
gra-1881	61	5	of	of	ADP
gra-1881	61	6	skin	skin	NOUN
gra-1881	61	7	and	and	CCONJ
gra-1881	61	8	mucous	mucous	ADJ
gra-1881	61	9	membrane	membrane	NOUN
gra-1881	61	10	was	be	AUX
gra-1881	61	11	seen	see	VERB
gra-1881	61	12	in	in	ADP
gra-1881	61	13	3	3	NUM
gra-1881	61	14	weekly	weekly	NOUN
gra-1881	61	15	(	(	PUNCT
gra-1881	61	16	40	40	NUM
gra-1881	61	17	%	%	NOUN
gra-1881	61	18	vs	vs	ADP
gra-1881	61	19	33	33	NUM
gra-1881	61	20	%	%	NOUN
gra-1881	61	21	)	)	PUNCT
gra-1881	61	22	which	which	PRON
gra-1881	61	23	was	be	AUX
gra-1881	61	24	probably	probably	ADV
gra-1881	61	25	attributed	attribute	VERB
gra-1881	61	26	to	to	ADP
gra-1881	61	27	delivery	delivery	NOUN
gra-1881	61	28	of	of	ADP
gra-1881	61	29	chemotherapy	chemotherapy	NOUN
gra-1881	61	30	in	in	ADP
gra-1881	61	31	divided	divide	VERB
gra-1881	61	32	doses	dose	NOUN
gra-1881	61	33	.	.	PUNCT
gra-1881	62	1	in	in	ADP
gra-1881	62	2	our	our	PRON
gra-1881	62	3	study	study	NOUN
gra-1881	62	4	there	there	PRON
gra-1881	62	5	was	be	VERB
gra-1881	62	6	no	no	DET
gra-1881	62	7	signicant	signicant	ADJ
gra-1881	62	8	difference	difference	NOUN
gra-1881	62	9	regarding	regard	VERB
gra-1881	62	10	hematologic	hematologic	NOUN
gra-1881	62	11	toxicity	toxicity	NOUN
gra-1881	62	12	,	,	PUNCT
gra-1881	62	13	nephrotoxicity	nephrotoxicity	NOUN
gra-1881	62	14	and	and	CCONJ
gra-1881	62	15	vomiting	vomiting	NOUN
gra-1881	62	16	between	between	ADP
gra-1881	62	17	both	both	DET
gra-1881	62	18	groups	group	NOUN
gra-1881	62	19	due	due	ADJ
gra-1881	62	20	to	to	ADP
gra-1881	62	21	proper	proper	ADJ
gra-1881	62	22	hydration	hydration	NOUN
gra-1881	62	23	and	and	CCONJ
gra-1881	62	24	other	other	ADJ
gra-1881	62	25	symptomatic	symptomatic	ADJ
gra-1881	62	26	care	care	NOUN
gra-1881	62	27	measures	measure	NOUN
gra-1881	62	28	taken	take	VERB
gra-1881	62	29	along	along	ADP
gra-1881	62	30	with	with	ADP
gra-1881	62	31	regular	regular	ADJ
gra-1881	62	32	weekly	weekly	ADJ
gra-1881	62	33	check	check	NOUN
gra-1881	62	34	[	[	X
gra-1881	62	35	7	7	NUM
gra-1881	62	36	]	]	PUNCT
gra-1881	62	37	up.ugyun	up.ugyun	PRON
gra-1881	62	38	et	et	PROPN
gra-1881	62	39	al	al	PROPN
gra-1881	62	40	,	,	PUNCT
gra-1881	62	41	reported	report	VERB
gra-1881	62	42	similar	similar	ADJ
gra-1881	62	43	vomiting	vomiting	NOUN
gra-1881	62	44	in	in	ADP
gra-1881	62	45	both	both	DET
gra-1881	62	46	groups	group	NOUN
gra-1881	62	47	.	.	PUNCT
gra-1881	63	1	grade	grade	NOUN
gra-1881	63	2	3	3	NUM
gra-1881	63	3	-	-	SYM
gra-1881	63	4	4	4	NUM
gra-1881	63	5	nephrotoxicity	nephrotoxicity	NOUN
gra-1881	63	6	was	be	AUX
gra-1881	63	7	16.6	16.6	NUM
gra-1881	63	8	%	%	NOUN
gra-1881	63	9	in	in	ADP
gra-1881	63	10	3	3	NUM
gra-1881	63	11	weekly	weekly	ADJ
gra-1881	63	12	and	and	CCONJ
gra-1881	63	13	5	5	NUM
gra-1881	63	14	%	%	NOUN
gra-1881	63	15	in	in	ADP
gra-1881	63	16	weekly	weekly	ADJ
gra-1881	63	17	cisplatin	cisplatin	NOUN
gra-1881	63	18	group	group	NOUN
gra-1881	63	19	.	.	PUNCT
gra-1881	64	1	difference	difference	NOUN
gra-1881	64	2	being	be	AUX
gra-1881	64	3	statistically	statistically	ADV
gra-1881	64	4	insignicant	insignicant	ADJ
gra-1881	64	5	.	.	PUNCT
gra-1881	65	1	in	in	ADP
gra-1881	65	2	3	3	NUM
gra-1881	65	3	weekly	weekly	ADJ
gra-1881	65	4	group	group	NOUN
gra-1881	65	5	neutropenia	neutropenia	NOUN
gra-1881	65	6	was	be	AUX
gra-1881	65	7	mildly	mildly	ADV
gra-1881	65	8	[	[	X
gra-1881	65	9	10	10	NUM
gra-1881	65	10	]	]	X
gra-1881	65	11	higher	high	ADJ
gra-1881	65	12	.	.	PUNCT
gra-1881	65	13	.in	.in	PUNCT
gra-1881	66	1	study	study	VERB
gra-1881	66	2	by	by	ADP
gra-1881	66	3	ho	ho	PROPN
gra-1881	66	4	et	et	PROPN
gra-1881	66	5	al	al	PROPN
gra-1881	66	6	,	,	PUNCT
gra-1881	66	7	no	no	DET
gra-1881	66	8	signicant	signicant	ADJ
gra-1881	66	9	difference	difference	NOUN
gra-1881	66	10	was	be	AUX
gra-1881	66	11	seen	see	VERB
gra-1881	66	12	between	between	ADP
gra-1881	66	13	two	two	NUM
gra-1881	66	14	groups	group	NOUN
gra-1881	66	15	with	with	ADP
gra-1881	66	16	regard	regard	NOUN
gra-1881	66	17	to	to	ADP
gra-1881	66	18	grade	grade	PROPN
gra-1881	66	19	iii	iii	NUM
gra-1881	66	20	neutropenia	neutropenia	NOUN
gra-1881	66	21	,	,	PUNCT
gra-1881	66	22	there	there	PRON
gra-1881	66	23	was	be	VERB
gra-1881	66	24	similar	similar	ADJ
gra-1881	66	25	renal	renal	ADJ
gra-1881	66	26	toxicity	toxicity	NOUN
gra-1881	66	27	in	in	ADP
gra-1881	66	28	both	both	DET
gra-1881	66	29	groups	group	NOUN
gra-1881	66	30	and	and	CCONJ
gra-1881	66	31	no	no	DET
gra-1881	66	32	grade	grade	NOUN
gra-1881	66	33	3volume-9	3volume-9	NUM
gra-1881	66	34	,	,	PUNCT
gra-1881	66	35	issue-2	issue-2	PROPN
gra-1881	66	36	,	,	PUNCT
gra-1881	66	37	february-2020	february-2020	VERB
gra-1881	66	38	•	•	NUM
gra-1881	66	39	print	print	NOUN
gra-1881	66	40	issn	issn	PROPN
gra-1881	66	41	no	no	NOUN
gra-1881	66	42	.	.	PROPN
gra-1881	66	43	2277	2277	NUM
gra-1881	66	44	8160	8160	NUM
gra-1881	66	45	•	•	NOUN
gra-1881	66	46	doi	doi	NOUN
gra-1881	66	47	:	:	PUNCT
gra-1881	66	48	10.36106	10.36106	NUM
gra-1881	66	49	/	/	SYM
gra-1881	66	50	gjra	gjra	NOUN
gra-1881	66	51	site	site	NOUN
gra-1881	66	52	weekly	weekly	ADJ
gra-1881	66	53	group	group	NOUN
gra-1881	66	54	3	3	NUM
gra-1881	67	1	weekly	weekly	ADJ
gra-1881	67	2	group	group	NOUN
gra-1881	67	3	no	no	INTJ
gra-1881	67	4	.	.	PUNCT
gra-1881	68	1	%	%	INTJ
gra-1881	68	2	no	no	INTJ
gra-1881	68	3	.	.	PUNCT
gra-1881	69	1	%	%	NOUN
gra-1881	69	2	larynx	larynx	NOUN
gra-1881	69	3	6	6	NUM
gra-1881	69	4	24.0	24.0	NUM
gra-1881	69	5	5	5	NUM
gra-1881	69	6	20.0	20.0	NUM
gra-1881	69	7	oral	oral	ADJ
gra-1881	69	8	cavity	cavity	NOUN
gra-1881	69	9	13	13	NUM
gra-1881	69	10	52.0	52.0	NUM
gra-1881	69	11	10	10	NUM
gra-1881	69	12	40.0	40.0	NUM
gra-1881	69	13	pharynx	pharynx	NOUN
gra-1881	69	14	6	6	NUM
gra-1881	69	15	24.00	24.00	NUM
gra-1881	69	16	10	10	NUM
gra-1881	69	17	40.0	40.0	NUM
gra-1881	69	18	total	total	NOUN
gra-1881	69	19	25	25	NUM
gra-1881	69	20	100.0	100.0	NUM
gra-1881	69	21	25	25	NUM
gra-1881	69	22	100.0	100.0	NUM
gra-1881	69	23	toxicity	toxicity	NOUN
gra-1881	69	24	weekly	weekly	ADJ
gra-1881	69	25	group	group	NOUN
gra-1881	69	26	3	3	NUM
gra-1881	69	27	weekly	weekly	ADJ
gra-1881	69	28	group	group	NOUN
gra-1881	69	29	p	p	NOUN
gra-1881	69	30	value	value	NOUN
gra-1881	69	31	no	no	INTJ
gra-1881	69	32	.	.	PUNCT
gra-1881	70	1	%	%	INTJ
gra-1881	71	1	no	no	INTJ
gra-1881	71	2	.	.	PUNCT
gra-1881	72	1	%	%	NOUN
gra-1881	72	2	anemia	anemia	NOUN
gra-1881	72	3	grade	grade	NOUN
gra-1881	72	4	i	i	NOUN
gra-1881	72	5	8	8	NUM
gra-1881	72	6	32.0	32.0	NUM
gra-1881	72	7	8	8	NUM
gra-1881	72	8	36.36	36.36	NUM
gra-1881	72	9	0.75	0.75	NUM
gra-1881	72	10	grade	grade	NOUN
gra-1881	72	11	ii	ii	NOUN
gra-1881	72	12	8	8	NUM
gra-1881	72	13	32.0	32.0	NUM
gra-1881	72	14	9	9	NUM
gra-1881	72	15	40.91	40.91	NUM
gra-1881	72	16	0.526	0.526	NUM
gra-1881	72	17	grade	grade	NOUN
gra-1881	72	18	iii	iii	NOUN
gra-1881	72	19	4	4	NUM
gra-1881	72	20	16.0	16.0	NUM
gra-1881	72	21	4	4	NUM
gra-1881	72	22	18.18	18.18	NUM
gra-1881	72	23	0.84	0.84	NUM
gra-1881	72	24	leucopenia	leucopenia	NOUN
gra-1881	72	25	grade	grade	NOUN
gra-1881	72	26	i	i	NOUN
gra-1881	72	27	7	7	NUM
gra-1881	72	28	28.0	28.0	NUM
gra-1881	72	29	8	8	NUM
gra-1881	72	30	36.36	36.36	NUM
gra-1881	72	31	0.54	0.54	NUM
gra-1881	72	32	grade	grade	NOUN
gra-1881	72	33	ii	ii	PROPN
gra-1881	72	34	8	8	NUM
gra-1881	72	35	32.00	32.00	NUM
gra-1881	72	36	7	7	NUM
gra-1881	72	37	31.82	31.82	NUM
gra-1881	72	38	0.989	0.989	NUM
gra-1881	72	39	grade	grade	NOUN
gra-1881	72	40	iii	iii	NUM
gra-1881	72	41	2	2	NUM
gra-1881	72	42	8.00	8.00	NUM
gra-1881	72	43	3	3	NUM
gra-1881	72	44	13.64	13.64	NUM
gra-1881	72	45	0.53	0.53	NUM
gra-1881	72	46	renal	renal	ADJ
gra-1881	72	47	toxicity	toxicity	NOUN
gra-1881	72	48	grade	grade	NOUN
gra-1881	72	49	i	i	PRON
gra-1881	72	50	12	12	NUM
gra-1881	72	51	48.00	48.00	NUM
gra-1881	72	52	10	10	NUM
gra-1881	72	53	45.45	45.45	NUM
gra-1881	72	54	0.86	0.86	NUM
gra-1881	72	55	grade	grade	NOUN
gra-1881	72	56	ii	ii	PROPN
gra-1881	72	57	6	6	NUM
gra-1881	72	58	24.00	24.00	NUM
gra-1881	72	59	5	5	NUM
gra-1881	72	60	22.73	22.73	NUM
gra-1881	72	61	0.92	0.92	NUM
gra-1881	72	62	grade	grade	NOUN
gra-1881	72	63	iii	iii	NUM
gra-1881	72	64	2	2	NUM
gra-1881	72	65	8.00	8.00	NUM
gra-1881	72	66	2	2	NUM
gra-1881	72	67	9.09	9.09	NUM
gra-1881	72	68	0.89	0.89	NUM
gra-1881	72	69	vomiting	vomiting	NOUN
gra-1881	72	70	grade	grade	NOUN
gra-1881	72	71	i	i	NOUN
gra-1881	72	72	5	5	NUM
gra-1881	72	73	20.00	20.00	NUM
gra-1881	72	74	10	10	NUM
gra-1881	72	75	45.45	45.45	NUM
gra-1881	72	76	0.056	0.056	NUM
gra-1881	72	77	grade	grade	NOUN
gra-1881	72	78	ii	ii	PROPN
gra-1881	72	79	12	12	NUM
gra-1881	72	80	48.00	48.00	NUM
gra-1881	72	81	9	9	NUM
gra-1881	72	82	40.91	40.91	NUM
gra-1881	72	83	0.62	0.62	NUM
gra-1881	72	84	grade	grade	NOUN
gra-1881	72	85	iii	iii	PROPN
gra-1881	72	86	3	3	NUM
gra-1881	72	87	12.00	12.00	NUM
gra-1881	72	88	1	1	NUM
gra-1881	72	89	4.55	4.55	NUM
gra-1881	72	90	0.34	0.34	NUM
gra-1881	72	91	dermatitis	dermatitis	NOUN
gra-1881	72	92	grade	grade	NOUN
gra-1881	72	93	i	i	PRON
gra-1881	72	94	14	14	NUM
gra-1881	72	95	56.00	56.00	NUM
gra-1881	72	96	13	13	NUM
gra-1881	72	97	59.09	59.09	NUM
gra-1881	72	98	0.83	0.83	NUM
gra-1881	72	99	grade	grade	NOUN
gra-1881	72	100	ii	ii	PROPN
gra-1881	72	101	10	10	NUM
gra-1881	72	102	40.00	40.00	NUM
gra-1881	72	103	9	9	NUM
gra-1881	72	104	40.91	40.91	NUM
gra-1881	72	105	0.94	0.94	NUM
gra-1881	72	106	grade	grade	NOUN
gra-1881	72	107	iii	iii	NOUN
gra-1881	72	108	1	1	NUM
gra-1881	72	109	4.00	4.00	NUM
gra-1881	72	110	0	0	NUM
gra-1881	72	111	0.00	0.00	NUM
gra-1881	72	112	0.30	0.30	NUM
gra-1881	72	113	mucositis	mucositis	NOUN
gra-1881	72	114	0	0	NUM
gra-1881	73	1	0.00	0.00	NUM
gra-1881	73	2	0	0	NUM
gra-1881	73	3	0.00	0.00	NUM
gra-1881	73	4	grade	grade	NOUN
gra-1881	73	5	i	i	PRON
gra-1881	73	6	14	14	NUM
gra-1881	73	7	56.00	56.00	NUM
gra-1881	73	8	10	10	NUM
gra-1881	73	9	45.45	45.45	NUM
gra-1881	73	10	0.46	0.46	NUM
gra-1881	73	11	grade	grade	NOUN
gra-1881	73	12	ii	ii	PROPN
gra-1881	73	13	9	9	NUM
gra-1881	73	14	36.00	36.00	NUM
gra-1881	73	15	10	10	NUM
gra-1881	73	16	45.45	45.45	NUM
gra-1881	73	17	0.51	0.51	NUM
gra-1881	73	18	grade	grade	NOUN
gra-1881	73	19	iii	iii	NUM
gra-1881	73	20	2	2	NUM
gra-1881	73	21	8.00	8.00	NUM
gra-1881	73	22	2	2	NUM
gra-1881	73	23	9.09	9.09	NUM
gra-1881	73	24	0.89	0.89	NUM
gra-1881	73	25	4	4	NUM
gra-1881	73	26	renal	renal	ADJ
gra-1881	73	27	toxicity	toxicity	NOUN
gra-1881	73	28	was	be	AUX
gra-1881	73	29	seen	see	VERB
gra-1881	73	30	.	.	PUNCT
gra-1881	74	1	,	,	PUNCT
gra-1881	74	2	[	[	X
gra-1881	74	3	9]geeta	9]geeta	X
gra-1881	74	4	et	et	NOUN
gra-1881	74	5	al	al	PROPN
gra-1881	74	6	reported	report	VERB
gra-1881	74	7	higher	high	ADJ
gra-1881	74	8	grade	grade	NOUN
gra-1881	74	9	iii	iii	NUM
gra-1881	74	10	hematological	hematological	ADJ
gra-1881	74	11	toxicity	toxicity	NOUN
gra-1881	74	12	in	in	ADP
gra-1881	74	13	weekly	weekly	ADJ
gra-1881	74	14	group	group	NOUN
gra-1881	74	15	.	.	PUNCT
gra-1881	75	1	grade	grade	NOUN
gra-1881	75	2	iii	iii	PROPN
gra-1881	75	3	anaemia	anaemia	NOUN
gra-1881	75	4	was	be	AUX
gra-1881	75	5	12.5	12.5	NUM
gra-1881	75	6	%	%	NOUN
gra-1881	75	7	in	in	ADP
gra-1881	75	8	weekly	weekly	ADJ
gra-1881	75	9	and	and	CCONJ
gra-1881	75	10	4	4	NUM
gra-1881	75	11	%	%	NOUN
gra-1881	75	12	in	in	ADP
gra-1881	75	13	3	3	NUM
gra-1881	75	14	weekly	weekly	ADJ
gra-1881	75	15	group	group	NOUN
gra-1881	75	16	.	.	PUNCT
gra-1881	76	1	grade	grade	PROPN
gra-1881	76	2	iii	iii	PROPN
gra-1881	76	3	neutropenia	neutropenia	NOUN
gra-1881	76	4	was	be	AUX
gra-1881	76	5	also	also	ADV
gra-1881	76	6	higher	high	ADJ
gra-1881	76	7	in	in	ADP
gra-1881	76	8	weekly	weekly	ADJ
gra-1881	76	9	group	group	NOUN
gra-1881	76	10	.	.	PUNCT
gra-1881	77	1	grade	grade	NOUN
gra-1881	77	2	i	i	PRON
gra-1881	77	3	thrombocytopenia	thrombocytopenia	PROPN
gra-1881	77	4	was	be	AUX
gra-1881	77	5	8	8	NUM
gra-1881	77	6	%	%	NOUN
gra-1881	77	7	in	in	ADP
gra-1881	77	8	3	3	NUM
gra-1881	77	9	weekly	weekly	ADJ
gra-1881	77	10	and	and	CCONJ
gra-1881	77	11	6	6	NUM
gra-1881	77	12	%	%	NOUN
gra-1881	77	13	in	in	ADP
gra-1881	77	14	weekly	weekly	ADJ
gra-1881	77	15	group	group	NOUN
gra-1881	77	16	.	.	PUNCT
gra-1881	78	1	in	in	ADP
gra-1881	78	2	our	our	PRON
gra-1881	78	3	study	study	NOUN
gra-1881	78	4	,	,	PUNCT
gra-1881	78	5	in	in	ADP
gra-1881	78	6	group	group	PROPN
gra-1881	78	7	a	a	NOUN
gra-1881	78	8	,	,	PUNCT
gra-1881	78	9	8	8	NUM
gra-1881	78	10	(	(	PUNCT
gra-1881	78	11	32	32	NUM
gra-1881	78	12	%	%	NOUN
gra-1881	78	13	)	)	PUNCT
gra-1881	78	14	patients	patient	NOUN
gra-1881	78	15	had	have	VERB
gra-1881	78	16	grade	grade	NOUN
gra-1881	78	17	i	i	PROPN
gra-1881	78	18	,	,	PUNCT
gra-1881	78	19	8	8	NUM
gra-1881	78	20	(	(	PUNCT
gra-1881	78	21	32	32	NUM
gra-1881	78	22	%	%	NOUN
gra-1881	78	23	)	)	PUNCT
gra-1881	78	24	patients	patient	NOUN
gra-1881	78	25	had	have	VERB
gra-1881	78	26	grade	grade	NOUN
gra-1881	78	27	ii	ii	PROPN
gra-1881	78	28	and	and	CCONJ
gra-1881	78	29	4	4	NUM
gra-1881	78	30	(	(	PUNCT
gra-1881	78	31	16	16	NUM
gra-1881	78	32	%	%	NOUN
gra-1881	78	33	)	)	PUNCT
gra-1881	79	1	patients	patient	NOUN
gra-1881	79	2	had	have	VERB
gra-1881	79	3	grade	grade	NOUN
gra-1881	79	4	iii	iii	NOUN
gra-1881	79	5	anemia	anemia	NOUN
gra-1881	79	6	.	.	PUNCT
gra-1881	80	1	in	in	ADP
gra-1881	80	2	group	group	PROPN
gra-1881	80	3	b	b	PROPN
gra-1881	80	4	,	,	PUNCT
gra-1881	80	5	8	8	NUM
gra-1881	80	6	(	(	PUNCT
gra-1881	80	7	36.36	36.36	NUM
gra-1881	80	8	%	%	NOUN
gra-1881	80	9	)	)	PUNCT
gra-1881	80	10	patients	patient	NOUN
gra-1881	80	11	had	have	VERB
gra-1881	80	12	grade	grade	NOUN
gra-1881	80	13	i	i	PRON
gra-1881	80	14	,	,	PUNCT
gra-1881	80	15	9	9	NUM
gra-1881	80	16	(	(	PUNCT
gra-1881	80	17	40.91	40.91	NUM
gra-1881	80	18	)	)	PUNCT
gra-1881	80	19	patients	patient	NOUN
gra-1881	80	20	had	have	VERB
gra-1881	80	21	grade	grade	NOUN
gra-1881	80	22	ii	ii	PROPN
gra-1881	80	23	and	and	CCONJ
gra-1881	80	24	4	4	NUM
gra-1881	80	25	(	(	PUNCT
gra-1881	80	26	18.18	18.18	NUM
gra-1881	80	27	)	)	PUNCT
gra-1881	80	28	patients	patient	NOUN
gra-1881	80	29	had	have	VERB
gra-1881	80	30	grade	grade	NOUN
gra-1881	80	31	iii	iii	NOUN
gra-1881	80	32	anemia	anemia	NOUN
gra-1881	80	33	with	with	ADP
gra-1881	80	34	no	no	DET
gra-1881	80	35	signicant	signicant	ADJ
gra-1881	80	36	statistical	statistical	ADJ
gra-1881	80	37	difference	difference	NOUN
gra-1881	80	38	and	and	CCONJ
gra-1881	80	39	regarding	regard	VERB
gra-1881	80	40	thrombocytopenia	thrombocytopenia	PROPN
gra-1881	80	41	,	,	PUNCT
gra-1881	80	42	in	in	ADP
gra-1881	80	43	group	group	PROPN
gra-1881	80	44	a	a	NOUN
gra-1881	80	45	,	,	PUNCT
gra-1881	80	46	4	4	NUM
gra-1881	80	47	(	(	PUNCT
gra-1881	80	48	16	16	NUM
gra-1881	80	49	%	%	NOUN
gra-1881	80	50	)	)	PUNCT
gra-1881	80	51	patients	patient	NOUN
gra-1881	80	52	had	have	VERB
gra-1881	80	53	grade	grade	NOUN
gra-1881	80	54	i	i	PRON
gra-1881	80	55	,	,	PUNCT
gra-1881	80	56	5	5	NUM
gra-1881	80	57	(	(	PUNCT
gra-1881	80	58	20	20	NUM
gra-1881	80	59	%	%	NOUN
gra-1881	80	60	)	)	PUNCT
gra-1881	80	61	patients	patient	NOUN
gra-1881	80	62	had	have	VERB
gra-1881	80	63	grade	grade	PROPN
gra-1881	80	64	ii	ii	PROPN
gra-1881	80	65	,	,	PUNCT
gra-1881	80	66	3	3	NUM
gra-1881	80	67	(	(	PUNCT
gra-1881	80	68	12	12	NUM
gra-1881	80	69	%	%	NOUN
gra-1881	80	70	)	)	PUNCT
gra-1881	81	1	patients	patient	NOUN
gra-1881	81	2	had	have	VERB
gra-1881	81	3	grade	grade	NOUN
gra-1881	81	4	iii	iii	NUM
gra-1881	81	5	thrombocytopenia	thrombocytopenia	PROPN
gra-1881	81	6	.	.	PUNCT
gra-1881	82	1	in	in	ADP
gra-1881	82	2	group	group	PROPN
gra-1881	82	3	b	b	PROPN
gra-1881	82	4	,	,	PUNCT
gra-1881	82	5	4	4	NUM
gra-1881	82	6	(	(	PUNCT
gra-1881	82	7	18.18	18.18	NUM
gra-1881	82	8	%	%	NOUN
gra-1881	82	9	)	)	PUNCT
gra-1881	82	10	patients	patient	NOUN
gra-1881	82	11	had	have	VERB
gra-1881	82	12	grade	grade	NOUN
gra-1881	82	13	i	i	PRON
gra-1881	82	14	,	,	PUNCT
gra-1881	82	15	2	2	NUM
gra-1881	82	16	(	(	PUNCT
gra-1881	82	17	9.09	9.09	NUM
gra-1881	82	18	%	%	NOUN
gra-1881	82	19	)	)	PUNCT
gra-1881	82	20	patients	patient	NOUN
gra-1881	82	21	had	have	VERB
gra-1881	82	22	grade	grade	PROPN
gra-1881	82	23	ii	ii	PROPN
gra-1881	82	24	,	,	PUNCT
gra-1881	82	25	4	4	NUM
gra-1881	82	26	(	(	PUNCT
gra-1881	82	27	18.18	18.18	NUM
gra-1881	82	28	%	%	NOUN
gra-1881	82	29	)	)	PUNCT
gra-1881	83	1	patients	patient	NOUN
gra-1881	83	2	had	have	VERB
gra-1881	83	3	grade	grade	NOUN
gra-1881	83	4	iii	iii	NUM
gra-1881	83	5	thrombocytopenia	thrombocytopenia	PROPN
gra-1881	83	6	.	.	PUNCT
gra-1881	84	1	no	no	DET
gra-1881	84	2	signicant	signicant	ADJ
gra-1881	84	3	statistical	statistical	ADJ
gra-1881	84	4	difference	difference	NOUN
gra-1881	84	5	was	be	AUX
gra-1881	84	6	seen	see	VERB
gra-1881	84	7	between	between	ADP
gra-1881	84	8	both	both	DET
gra-1881	84	9	groups	group	NOUN
gra-1881	84	10	in	in	ADP
gra-1881	84	11	terms	term	NOUN
gra-1881	84	12	of	of	ADP
gra-1881	84	13	anemia	anemia	NOUN
gra-1881	84	14	and	and	CCONJ
gra-1881	84	15	thrombocytopenia	thrombocytopenia	NOUN
gra-1881	84	16	and	and	CCONJ
gra-1881	84	17	both	both	PRON
gra-1881	84	18	were	be	AUX
gra-1881	84	19	taken	take	VERB
gra-1881	84	20	care	care	NOUN
gra-1881	84	21	of	of	ADP
gra-1881	84	22	with	with	ADP
gra-1881	84	23	blood	blood	NOUN
gra-1881	84	24	transfusions	transfusion	NOUN
gra-1881	84	25	wherever	wherever	SCONJ
gra-1881	84	26	needed	need	VERB
gra-1881	84	27	.	.	PUNCT
gra-1881	85	1	no	no	DET
gra-1881	85	2	grade	grade	NOUN
gra-1881	85	3	iv	iv	NOUN
gra-1881	85	4	anemia	anemia	NOUN
gra-1881	85	5	or	or	CCONJ
gra-1881	85	6	thrombocytopenia	thrombocytopenia	NOUN
gra-1881	85	7	was	be	AUX
gra-1881	85	8	seen	see	VERB
gra-1881	85	9	.	.	PUNCT
gra-1881	86	1	in	in	ADP
gra-1881	86	2	our	our	PRON
gra-1881	86	3	study	study	NOUN
gra-1881	86	4	,	,	PUNCT
gra-1881	86	5	in	in	ADP
gra-1881	86	6	group	group	PROPN
gra-1881	86	7	a	a	PROPN
gra-1881	86	8	,	,	PUNCT
gra-1881	86	9	22	22	NUM
gra-1881	86	10	out	out	ADP
gra-1881	86	11	of	of	ADP
gra-1881	86	12	25	25	NUM
gra-1881	86	13	patients	patient	NOUN
gra-1881	86	14	completed	complete	VERB
gra-1881	86	15	treatment	treatment	NOUN
gra-1881	86	16	without	without	ADP
gra-1881	86	17	any	any	DET
gra-1881	86	18	breaks	break	NOUN
gra-1881	86	19	whereas	whereas	SCONJ
gra-1881	86	20	in	in	SCONJ
gra-1881	86	21	group	group	PROPN
gra-1881	86	22	b	b	PROPN
gra-1881	86	23	,	,	PUNCT
gra-1881	86	24	out	out	ADP
gra-1881	86	25	of	of	ADP
gra-1881	86	26	22	22	NUM
gra-1881	86	27	patients	patient	NOUN
gra-1881	86	28	20	20	NUM
gra-1881	86	29	patients	patient	NOUN
gra-1881	86	30	completed	complete	VERB
gra-1881	86	31	treatment	treatment	NOUN
gra-1881	86	32	without	without	ADP
gra-1881	86	33	any	any	DET
gra-1881	86	34	breaks	break	NOUN
gra-1881	86	35	and	and	CCONJ
gra-1881	86	36	due	due	ADP
gra-1881	86	37	to	to	ADP
gra-1881	86	38	severe	severe	ADJ
gra-1881	86	39	dermatitis	dermatitis	NOUN
gra-1881	86	40	and	and	CCONJ
gra-1881	86	41	mucositis	mucositis	NOUN
gra-1881	86	42	along	along	ADP
gra-1881	86	43	with	with	ADP
gra-1881	86	44	[	[	X
gra-1881	86	45	11],hematological	11],hematological	ADJ
gra-1881	86	46	toxicity	toxicity	NOUN
gra-1881	86	47	.	.	PUNCT
gra-1881	87	1	jemal	jemal	ADJ
gra-1881	87	2	a	a	PRON
gra-1881	87	3	in	in	ADP
gra-1881	87	4	his	his	PRON
gra-1881	87	5	study	study	NOUN
gra-1881	87	6	showed	show	VERB
gra-1881	87	7	that	that	SCONJ
gra-1881	87	8	signicant	signicant	ADJ
gra-1881	87	9	number	number	NOUN
gra-1881	87	10	of	of	ADP
gra-1881	87	11	patients	patient	NOUN
gra-1881	87	12	could	could	AUX
gra-1881	87	13	not	not	PART
gra-1881	87	14	receive	receive	VERB
gra-1881	87	15	the	the	DET
gra-1881	87	16	third	third	ADJ
gra-1881	87	17	cisplatin	cisplatin	NOUN
gra-1881	87	18	dose	dose	NOUN
gra-1881	87	19	of	of	ADP
gra-1881	87	20	100	100	NUM
gra-1881	87	21	mg	mg	PROPN
gra-1881	87	22	/	/	SYM
gra-1881	87	23	m2	m2	PROPN
gra-1881	87	24	.	.	PROPN
gra-1881	88	1	in	in	ADP
gra-1881	88	2	our	our	PRON
gra-1881	88	3	study	study	NOUN
gra-1881	88	4	in	in	ADP
gra-1881	88	5	group	group	PROPN
gra-1881	88	6	b	b	PROPN
gra-1881	88	7	,	,	PUNCT
gra-1881	88	8	3	3	NUM
gra-1881	88	9	patients	patient	NOUN
gra-1881	88	10	did	do	AUX
gra-1881	88	11	not	not	PART
gra-1881	88	12	complete	complete	VERB
gra-1881	88	13	full	full	ADJ
gra-1881	88	14	course	course	NOUN
gra-1881	88	15	of	of	ADP
gra-1881	88	16	treatment	treatment	NOUN
gra-1881	88	17	and	and	CCONJ
gra-1881	88	18	therefore	therefore	ADV
gra-1881	88	19	were	be	AUX
gra-1881	88	20	excluded	exclude	VERB
gra-1881	88	21	from	from	ADP
gra-1881	88	22	the	the	DET
gra-1881	88	23	study	study	NOUN
gra-1881	88	24	.	.	PUNCT
gra-1881	89	1	compliance	compliance	NOUN
gra-1881	89	2	is	be	AUX
gra-1881	89	3	another	another	DET
gra-1881	89	4	signicant	signicant	ADJ
gra-1881	89	5	problem	problem	NOUN
gra-1881	89	6	with	with	ADP
gra-1881	89	7	the	the	DET
gra-1881	89	8	standard	standard	ADJ
gra-1881	89	9	cisplatin	cisplatin	PROPN
gra-1881	89	10	100mg	100mg	PROPN
gra-1881	89	11	/	/	SYM
gra-1881	89	12	m2	m2	PROPN
gra-1881	89	13	concurrent	concurrent	ADJ
gra-1881	89	14	chemo	chemo	NOUN
gra-1881	89	15	-	-	PUNCT
gra-1881	89	16	radiotherapy	radiotherapy	NOUN
gra-1881	89	17	regimen.in	regimen.in	PRON
gra-1881	89	18	our	our	PRON
gra-1881	89	19	study	study	NOUN
gra-1881	89	20	in	in	ADP
gra-1881	89	21	which	which	PRON
gra-1881	89	22	the	the	DET
gra-1881	89	23	compliance	compliance	NOUN
gra-1881	89	24	was	be	AUX
gra-1881	89	25	100	100	NUM
gra-1881	89	26	%	%	NOUN
gra-1881	89	27	in	in	ADP
gra-1881	89	28	group	group	PROPN
gra-1881	89	29	a	a	PRON
gra-1881	89	30	and	and	CCONJ
gra-1881	89	31	88	88	NUM
gra-1881	89	32	%	%	NOUN
gra-1881	89	33	in	in	ADP
gra-1881	89	34	group	group	PROPN
gra-1881	89	35	b	b	PROPN
gra-1881	89	36	which	which	PRON
gra-1881	89	37	was	be	AUX
gra-1881	89	38	similar	similar	ADJ
gra-1881	89	39	to	to	ADP
gra-1881	89	40	the	the	DET
gra-1881	89	41	study	study	NOUN
gra-1881	89	42	done	do	VERB
gra-1881	89	43	previously	previously	ADV
gra-1881	89	44	by	by	ADP
gra-1881	89	45	eortc	eortc	ADJ
gra-1881	89	46	and	and	CCONJ
gra-1881	89	47	rtog	rtog	ADJ
gra-1881	89	48	conclusions	conclusion	NOUN
gra-1881	89	49	in	in	ADP
gra-1881	89	50	our	our	PRON
gra-1881	89	51	study	study	NOUN
gra-1881	89	52	comparison	comparison	NOUN
gra-1881	89	53	of	of	ADP
gra-1881	89	54	both	both	DET
gra-1881	89	55	regimens	regimen	NOUN
gra-1881	89	56	given	give	VERB
gra-1881	89	57	concurrently	concurrently	ADV
gra-1881	89	58	with	with	ADP
gra-1881	89	59	radiotherapy	radiotherapy	NOUN
gra-1881	89	60	showed	show	VERB
gra-1881	89	61	statistically	statistically	ADV
gra-1881	89	62	similar	similar	ADJ
gra-1881	89	63	response	response	NOUN
gra-1881	89	64	rates	rate	NOUN
gra-1881	89	65	and	and	CCONJ
gra-1881	89	66	adverse	adverse	ADJ
gra-1881	89	67	event	event	NOUN
gra-1881	89	68	prole	prole	PROPN
gra-1881	89	69	.	.	PUNCT
gra-1881	90	1	in	in	ADP
gra-1881	90	2	terms	term	NOUN
gra-1881	90	3	of	of	ADP
gra-1881	90	4	tumor	tumor	NOUN
gra-1881	90	5	response	response	NOUN
gra-1881	90	6	and	and	CCONJ
gra-1881	90	7	toxicity	toxicity	NOUN
gra-1881	90	8	both	both	CCONJ
gra-1881	90	9	the	the	DET
gra-1881	90	10	regimens	regimen	NOUN
gra-1881	90	11	had	have	VERB
gra-1881	90	12	equal	equal	ADJ
gra-1881	90	13	results	result	NOUN
gra-1881	90	14	due	due	ADP
gra-1881	90	15	to	to	ADP
gra-1881	90	16	more	more	ADV
gra-1881	90	17	potent	potent	ADJ
gra-1881	90	18	medications	medication	NOUN
gra-1881	90	19	available	available	ADJ
gra-1881	90	20	to	to	PART
gra-1881	90	21	manage	manage	VERB
gra-1881	90	22	them	they	PRON
gra-1881	90	23	.	.	PUNCT
gra-1881	91	1	however	however	ADV
gra-1881	91	2	better	well	ADJ
gra-1881	91	3	compliance	compliance	NOUN
gra-1881	91	4	was	be	AUX
gra-1881	91	5	seen	see	VERB
gra-1881	91	6	in	in	ADP
gra-1881	91	7	weekly	weekly	ADJ
gra-1881	91	8	cisplatin	cisplatin	NOUN
gra-1881	91	9	group	group	NOUN
gra-1881	91	10	as	as	SCONJ
gra-1881	91	11	compared	compare	VERB
gra-1881	91	12	to	to	ADP
gra-1881	91	13	3	3	NUM
gra-1881	91	14	weekly	weekly	ADJ
gra-1881	91	15	due	due	ADP
gra-1881	91	16	to	to	ADP
gra-1881	91	17	toxicities	toxicity	NOUN
gra-1881	91	18	.	.	PUNCT
gra-1881	92	1	thus	thus	ADV
gra-1881	92	2	use	use	VERB
gra-1881	92	3	weekly	weekly	ADJ
gra-1881	92	4	cisplatin	cisplatin	NOUN
gra-1881	92	5	can	can	AUX
gra-1881	92	6	be	be	AUX
gra-1881	92	7	used	use	VERB
gra-1881	92	8	nowadays	nowadays	ADV
gra-1881	92	9	due	due	ADJ
gra-1881	92	10	to	to	ADP
gra-1881	92	11	less	less	ADJ
gra-1881	92	12	tolerability	tolerability	NOUN
gra-1881	92	13	of	of	ADP
gra-1881	92	14	3	3	NUM
gra-1881	92	15	weekly	weekly	ADJ
gra-1881	92	16	regimen	regiman	NOUN
gra-1881	92	17	in	in	ADP
gra-1881	92	18	some	some	DET
gra-1881	92	19	settings	setting	NOUN
gra-1881	92	20	because	because	SCONJ
gra-1881	92	21	of	of	ADP
gra-1881	92	22	which	which	PRON
gra-1881	92	23	less	less	ADJ
gra-1881	92	24	patients	patient	NOUN
gra-1881	92	25	achieve	achieve	VERB
gra-1881	92	26	cumulative	cumulative	ADJ
gra-1881	92	27	dose	dose	NOUN
gra-1881	92	28	beyond	beyond	ADP
gra-1881	92	29	200	200	NUM
gra-1881	92	30	mg	mg	PROPN
gra-1881	92	31	/	/	SYM
gra-1881	92	32	m2	m2	PROPN
gra-1881	92	33	,	,	PUNCT
gra-1881	92	34	lowering	lower	VERB
gra-1881	92	35	chemotherapy	chemotherapy	NOUN
gra-1881	92	36	dose	dose	NOUN
gra-1881	92	37	intensity	intensity	NOUN
gra-1881	92	38	.	.	PUNCT
gra-1881	93	1	references	reference	NOUN
gra-1881	93	2	:	:	PUNCT
gra-1881	94	1	1	1	X
gra-1881	94	2	.	.	X
gra-1881	94	3	agarwal	agarwal	PROPN
gra-1881	94	4	ak	ak	PROPN
gra-1881	94	5	,	,	PUNCT
gra-1881	94	6	sethi	sethi	PROPN
gra-1881	94	7	a	a	PROPN
gra-1881	94	8	,	,	PUNCT
gra-1881	94	9	sareen	sareen	PROPN
gra-1881	94	10	d	d	PROPN
gra-1881	94	11	,	,	PUNCT
gra-1881	94	12	dhingra	dhingra	PROPN
gra-1881	94	13	s.	s.	PROPN
gra-1881	94	14	treatment	treatment	PROPN
gra-1881	94	15	delay	delay	NOUN
gra-1881	94	16	in	in	ADP
gra-1881	94	17	oral	oral	ADJ
gra-1881	94	18	and	and	CCONJ
gra-1881	94	19	oropharyngeal	oropharyngeal	ADJ
gra-1881	94	20	cancer	cancer	NOUN
gra-1881	94	21	in	in	ADP
gra-1881	94	22	our	our	PRON
gra-1881	94	23	population	population	NOUN
gra-1881	94	24	:	:	PUNCT
gra-1881	94	25	the	the	DET
gra-1881	94	26	role	role	NOUN
gra-1881	94	27	of	of	ADP
gra-1881	94	28	socio	socio	NOUN
gra-1881	94	29	-	-	PUNCT
gra-1881	94	30	economic	economic	ADJ
gra-1881	94	31	factors	factor	NOUN
gra-1881	94	32	and	and	CCONJ
gra-1881	94	33	health	health	NOUN
gra-1881	94	34	-	-	PUNCT
gra-1881	94	35	seeking	seek	VERB
gra-1881	94	36	behaviour	behaviour	NOUN
gra-1881	94	37	.	.	PUNCT
gra-1881	95	1	indian	indian	PROPN
gra-1881	95	2	j	j	PROPN
gra-1881	95	3	otolaryngol	otolaryngol	PROPN
gra-1881	95	4	head	head	NOUN
gra-1881	95	5	neck	neck	NOUN
gra-1881	95	6	surg	surg	NOUN
gra-1881	95	7	.	.	PUNCT
gra-1881	96	1	2011;63:145–50	2011;63:145–50	X
gra-1881	96	2	.	.	NOUN
gra-1881	96	3	2	2	NUM
gra-1881	96	4	.	.	X
gra-1881	96	5	patel	patel	PROPN
gra-1881	96	6	ua	ua	PROPN
gra-1881	96	7	,	,	PUNCT
gra-1881	96	8	lynn	lynn	PROPN
gra-1881	96	9	-	-	PUNCT
gra-1881	96	10	macrae	macrae	PROPN
gra-1881	96	11	a	a	PROPN
gra-1881	96	12	,	,	PUNCT
gra-1881	96	13	rosen	rosen	PROPN
gra-1881	96	14	f	f	PROPN
gra-1881	96	15	,	,	PUNCT
gra-1881	96	16	holloway	holloway	PROPN
gra-1881	96	17	n	n	CCONJ
gra-1881	96	18	,	,	PUNCT
gra-1881	96	19	kern	kern	PROPN
gra-1881	96	20	r.	r.	PROPN
gra-1881	96	21	advanced	advanced	ADJ
gra-1881	96	22	stage	stage	NOUN
gra-1881	96	23	of	of	ADP
gra-1881	96	24	head	head	NOUN
gra-1881	96	25	and	and	CCONJ
gra-1881	96	26	neck	neck	NOUN
gra-1881	96	27	cancer	cancer	NOUN
gra-1881	96	28	at	at	ADP
gra-1881	96	29	a	a	DET
gra-1881	96	30	tertiary	tertiary	ADJ
gra-1881	96	31	-	-	PUNCT
gra-1881	96	32	care	care	NOUN
gra-1881	96	33	county	county	NOUN
gra-1881	96	34	hospital	hospital	NOUN
gra-1881	96	35	.	.	PUNCT
gra-1881	97	1	laryngoscope	laryngoscope	NOUN
gra-1881	97	2	.	.	PUNCT
gra-1881	98	1	2006;116:1473–7	2006;116:1473–7	NUM
gra-1881	98	2	3	3	NUM
gra-1881	98	3	.	.	PUNCT
gra-1881	98	4	chhetri	chhetri	PROPN
gra-1881	98	5	dk	dk	PROPN
gra-1881	98	6	,	,	PUNCT
gra-1881	98	7	rawnsley	rawnsley	PROPN
gra-1881	98	8	jd	jd	PROPN
gra-1881	98	9	,	,	PUNCT
gra-1881	98	10	calcaterra	calcaterra	PROPN
gra-1881	98	11	tc	tc	PROPN
gra-1881	98	12	.	.	PUNCT
gra-1881	98	13	carcinoma	carcinoma	NOUN
gra-1881	98	14	of	of	ADP
gra-1881	98	15	the	the	DET
gra-1881	98	16	buccal	buccal	ADJ
gra-1881	98	17	mucosa	mucosa	NOUN
gra-1881	98	18	.	.	PUNCT
gra-1881	99	1	otolaryngol	otolaryngol	ADJ
gra-1881	99	2	head	head	NOUN
gra-1881	99	3	neck	neck	NOUN
gra-1881	99	4	surg	surg	NOUN
gra-1881	99	5	.	.	PUNCT
gra-1881	100	1	2000;123:566–71	2000;123:566–71	NOUN
gra-1881	100	2	.	.	PUNCT
gra-1881	101	1	4	4	X
gra-1881	101	2	.	.	X
gra-1881	101	3	diaz	diaz	PROPN
gra-1881	101	4	em	em	PRON
gra-1881	101	5	,	,	PUNCT
gra-1881	101	6	holsinger	holsinger	PROPN
gra-1881	101	7	ffc	ffc	PROPN
gra-1881	101	8	,	,	PUNCT
gra-1881	101	9	zuniga	zuniga	PROPN
gra-1881	101	10	er	er	PROPN
gra-1881	101	11	,	,	PUNCT
gra-1881	101	12	roberts	roberts	PROPN
gra-1881	101	13	db	db	PROPN
gra-1881	101	14	,	,	PUNCT
gra-1881	101	15	sorensen	sorensen	PROPN
gra-1881	101	16	dm	dm	PROPN
gra-1881	101	17	.	.	PROPN
gra-1881	101	18	squamous	squamous	ADJ
gra-1881	101	19	cell	cell	NOUN
gra-1881	101	20	carcinoma	carcinoma	NOUN
gra-1881	101	21	of	of	ADP
gra-1881	101	22	the	the	DET
gra-1881	101	23	buccal	buccal	ADJ
gra-1881	101	24	mucosa	mucosa	NOUN
gra-1881	101	25	:	:	PUNCT
gra-1881	101	26	one	one	NUM
gra-1881	101	27	institution	institution	NOUN
gra-1881	101	28	’s	’s	PART
gra-1881	101	29	experience	experience	NOUN
gra-1881	101	30	with	with	ADP
gra-1881	101	31	119	119	NUM
gra-1881	101	32	previously	previously	ADV
gra-1881	101	33	untreated	untreated	ADJ
gra-1881	101	34	patients	patient	NOUN
gra-1881	101	35	.	.	PUNCT
gra-1881	102	1	head	head	NOUN
gra-1881	102	2	neck.2003;25:267–73	neck.2003;25:267–73	PROPN
gra-1881	102	3	.	.	PUNCT
gra-1881	103	1	5	5	X
gra-1881	103	2	.	.	NOUN
gra-1881	103	3	pignon	pignon	NOUN
gra-1881	103	4	jp	jp	PROPN
gra-1881	103	5	,	,	PUNCT
gra-1881	103	6	le	le	X
gra-1881	103	7	maitre	maitre	PROPN
gra-1881	103	8	a	a	PRON
gra-1881	103	9	,	,	PUNCT
gra-1881	103	10	maillard	maillard	NOUN
gra-1881	103	11	e	e	NOUN
gra-1881	103	12	,	,	PUNCT
gra-1881	103	13	bourhis	bourhis	PRON
gra-1881	103	14	j	j	PROPN
gra-1881	103	15	,	,	PUNCT
gra-1881	103	16	mach	mach	PROPN
gra-1881	103	17	-	-	PUNCT
gra-1881	103	18	nc	nc	PROPN
gra-1881	103	19	collaborative	collaborative	PROPN
gra-1881	103	20	group	group	NOUN
gra-1881	103	21	.	.	PUNCT
gra-1881	104	1	meta	meta	ADJ
gra-1881	104	2	-	-	PUNCT
gra-1881	104	3	analysis	analysis	NOUN
gra-1881	104	4	of	of	ADP
gra-1881	104	5	chemotherapy	chemotherapy	NOUN
gra-1881	104	6	in	in	ADP
gra-1881	104	7	head	head	NOUN
gra-1881	104	8	and	and	CCONJ
gra-1881	104	9	neck	neck	NOUN
gra-1881	104	10	cancer	cancer	NOUN
gra-1881	104	11	(	(	PUNCT
gra-1881	104	12	mach	mach	NOUN
gra-1881	104	13	-	-	PUNCT
gra-1881	104	14	nc	nc	PROPN
gra-1881	104	15	):	):	PUNCT
gra-1881	104	16	an	an	DET
gra-1881	104	17	update	update	NOUN
gra-1881	104	18	on	on	ADP
gra-1881	104	19	93	93	NUM
gra-1881	104	20	randomised	randomised	ADJ
gra-1881	104	21	trials	trial	NOUN
gra-1881	104	22	and	and	CCONJ
gra-1881	104	23	17,346	17,346	NUM
gra-1881	104	24	patients	patient	NOUN
gra-1881	104	25	radiotherapy	radiotherapy	NOUN
gra-1881	104	26	and	and	CCONJ
gra-1881	104	27	oncology	oncology	NOUN
gra-1881	104	28	2009	2009	NUM
gra-1881	104	29	;	;	PUNCT
gra-1881	104	30	92(1	92(1	NUM
gra-1881	104	31	):	):	PUNCT
gra-1881	104	32	4	4	NUM
gra-1881	104	33	-	-	SYM
gra-1881	104	34	14	14	NUM
gra-1881	104	35	.	.	PUNCT
gra-1881	105	1	6	6	NUM
gra-1881	105	2	.	.	PUNCT
gra-1881	105	3	aahmed	aahme	VERB
gra-1881	105	4	el	el	PROPN
gra-1881	105	5	-	-	NOUN
gra-1881	105	6	azony	azony	PROPN
gra-1881	105	7	,	,	PUNCT
gra-1881	105	8	abbas	abbas	PROPN
gra-1881	105	9	m.	m.	PROPN
gra-1881	105	10	sarhan	sarhan	PROPN
gra-1881	105	11	,	,	PUNCT
gra-1881	105	12	waleed	waleed	PROPN
gra-1881	105	13	e.	e.	PROPN
gra-1881	105	14	hamouda	hamouda	PROPN
gra-1881	105	15	,	,	PUNCT
gra-1881	105	16	mohammed	mohammed	PROPN
gra-1881	105	17	a.	a.	PROPN
gra-1881	105	18	mazrouh	mazrouh	PROPN
gra-1881	105	19	z.u.m.j	z.u.m.j	PROPN
gra-1881	105	20	.	.	PUNCT
gra-1881	105	21	vol	vol	NOUN
gra-1881	105	22	.	.	PUNCT
gra-1881	106	1	18;n.5;september	18;n.5;september	NUM
gra-1881	106	2	;	;	PUNCT
gra-1881	106	3	2012	2012	NUM
gra-1881	106	4	.	.	PUNCT
gra-1881	107	1	7	7	X
gra-1881	107	2	.	.	X
gra-1881	107	3	uygun	uygun	PROPN
gra-1881	107	4	k	k	PROPN
gra-1881	107	5	,	,	PUNCT
gra-1881	107	6	bilici	bilici	VERB
gra-1881	107	7	a	a	DET
gra-1881	107	8	,	,	PUNCT
gra-1881	107	9	karagol	karagol	NOUN
gra-1881	107	10	h	h	NOUN
gra-1881	107	11	,	,	PUNCT
gra-1881	107	12	et	et	PROPN
gra-1881	107	13	al	al	PROPN
gra-1881	107	14	.	.	PUNCT
gra-1881	107	15	:	:	PUNCT
gra-1881	108	1	the	the	DET
gra-1881	108	2	comparision	comparision	NOUN
gra-1881	108	3	of	of	ADP
gra-1881	108	4	weekly	weekly	ADJ
gra-1881	108	5	and	and	CCONJ
gra-1881	108	6	three	three	NUM
gra-1881	108	7	weekly	weekly	ADJ
gra-1881	108	8	cisplatin	cisplatin	NOUN
gra-1881	108	9	chemotherapy	chemotherapy	NOUN
gra-1881	108	10	concurrent	concurrent	NOUN
gra-1881	108	11	with	with	ADP
gra-1881	108	12	radiotherapy	radiotherapy	NOUN
gra-1881	108	13	in	in	ADP
gra-1881	108	14	patients	patient	NOUN
gra-1881	108	15	with	with	ADP
gra-1881	108	16	previously	previously	ADV
gra-1881	108	17	untreated	untreate	VERB
gra-1881	108	18	inoperable	inoperable	ADJ
gra-1881	108	19	non	non	ADJ
gra-1881	108	20	-	-	ADJ
gra-1881	108	21	metastatic	metastatic	ADJ
gra-1881	108	22	squamous	squamous	ADJ
gra-1881	108	23	cell	cell	NOUN
gra-1881	108	24	carcinoma	carcinoma	NOUN
gra-1881	108	25	of	of	ADP
gra-1881	108	26	the	the	DET
gra-1881	108	27	head	head	NOUN
gra-1881	108	28	and	and	CCONJ
gra-1881	108	29	neck	neck	NOUN
gra-1881	108	30	.	.	PUNCT
gra-1881	109	1	cancer	cancer	NOUN
gra-1881	109	2	chemother	chemother	PROPN
gra-1881	109	3	pharmacol	pharmacol	PROPN
gra-1881	109	4	2009	2009	NUM
gra-1881	109	5	,	,	PUNCT
gra-1881	109	6	64:601	64:601	NUM
gra-1881	109	7	-	-	SYM
gra-1881	109	8	605	605	NUM
gra-1881	109	9	.	.	NOUN
gra-1881	109	10	8	8	NUM
gra-1881	109	11	.	.	X
gra-1881	110	1	kose	kose	PROPN
gra-1881	110	2	f	f	PROPN
gra-1881	110	3	,	,	PUNCT
gra-1881	110	4	besen	besen	PROPN
gra-1881	110	5	a	a	PROPN
gra-1881	110	6	,	,	PUNCT
gra-1881	110	7	sumbul	sumbul	PROPN
gra-1881	110	8	t	t	PROPN
gra-1881	110	9	,	,	PUNCT
gra-1881	110	10	et	et	PROPN
gra-1881	110	11	al	al	PROPN
gra-1881	110	12	.	.	PUNCT
gra-1881	110	13	:	:	PUNCT
gra-1881	111	1	weekly	weekly	ADJ
gra-1881	111	2	cisplatin	cisplatin	NOUN
gra-1881	111	3	versus	versus	ADP
gra-1881	111	4	standard	standard	ADJ
gra-1881	111	5	three	three	NUM
gra-1881	111	6	weekly	weekly	ADJ
gra-1881	111	7	cisplatin	cisplatin	NOUN
gra-1881	111	8	in	in	ADP
gra-1881	111	9	concurrent	concurrent	ADJ
gra-1881	111	10	chemoradiotherapy	chemoradiotherapy	NOUN
gra-1881	111	11	of	of	ADP
gra-1881	111	12	head	head	NOUN
gra-1881	111	13	and	and	CCONJ
gra-1881	111	14	neck	neck	NOUN
gra-1881	111	15	cancer	cancer	NOUN
gra-1881	111	16	:	:	PUNCT
gra-1881	111	17	the	the	DET
gra-1881	111	18	baskent	baskent	ADJ
gra-1881	111	19	university	university	NOUN
gra-1881	111	20	experience	experience	NOUN
gra-1881	111	21	.	.	PUNCT
gra-1881	112	1	asian	asian	ADJ
gra-1881	112	2	pacic	pacic	PROPN
gra-1881	112	3	j	j	PROPN
gra-1881	112	4	cancer	cancer	NOUN
gra-1881	112	5	prev	prev	NOUN
gra-1881	112	6	2011;12,1185	2011;12,1185	NUM
gra-1881	112	7	-	-	SYM
gra-1881	112	8	1188	1188	NUM
gra-1881	112	9	.	.	PUNCT
gra-1881	113	1	9	9	NUM
gra-1881	113	2	.	.	PUNCT
gra-1881	113	3	geeta	geeta	PROPN
gra-1881	113	4	sn	sn	PROPN
gra-1881	113	5	,	,	PUNCT
gra-1881	113	6	padmanabhan	padmanabhan	PROPN
gra-1881	113	7	tk	tk	PROPN
gra-1881	113	8	,	,	PUNCT
gra-1881	113	9	samuel	samuel	PROPN
gra-1881	113	10	j	j	PROPN
gra-1881	113	11	et	et	PROPN
gra-1881	113	12	al	al	PROPN
gra-1881	113	13	:	:	PUNCT
gra-1881	113	14	comparision	comparision	NOUN
gra-1881	113	15	of	of	ADP
gra-1881	113	16	acute	acute	ADJ
gra-1881	113	17	toxicities	toxicity	NOUN
gra-1881	113	18	of	of	ADP
gra-1881	113	19	two	two	NUM
gra-1881	113	20	chemotherapy	chemotherapy	NOUN
gra-1881	113	21	schedules	schedule	NOUN
gra-1881	113	22	for	for	ADP
gra-1881	113	23	head	head	NOUN
gra-1881	113	24	and	and	CCONJ
gra-1881	113	25	neck	neck	NOUN
gra-1881	113	26	cancers	cancer	NOUN
gra-1881	113	27	.	.	PUNCT
gra-1881	114	1	jcrt	jcrt	ADJ
gra-1881	114	2	2006	2006	NUM
gra-1881	114	3	;	;	PUNCT
gra-1881	114	4	2(3):100	2(3):100	NUM
gra-1881	114	5	-	-	SYM
gra-1881	114	6	104	104	NUM
gra-1881	114	7	.	.	PUNCT
gra-1881	115	1	10	10	NUM
gra-1881	115	2	.	.	PUNCT
gra-1881	116	1	ho	ho	PROPN
gra-1881	116	2	kf	kf	PROPN
gra-1881	116	3	,	,	PUNCT
gra-1881	116	4	swindell	swindell	PROPN
gra-1881	116	5	r	r	NOUN
gra-1881	116	6	,	,	PUNCT
gra-1881	116	7	brammer	brammer	PROPN
gra-1881	116	8	cv	cv	PROPN
gra-1881	116	9	.	.	PROPN
gra-1881	116	10	dose	dose	PROPN
gra-1881	116	11	intensity	intensity	NOUN
gra-1881	116	12	comparision	comparision	NOUN
gra-1881	116	13	between	between	ADP
gra-1881	116	14	weekly	weekly	ADJ
gra-1881	116	15	and	and	CCONJ
gra-1881	116	16	3weekly	3weekly	NUM
gra-1881	116	17	cisplatin	cisplatin	NOUN
gra-1881	116	18	delievered	delievere	VERB
gra-1881	116	19	concurrently	concurrently	ADV
gra-1881	116	20	with	with	ADP
gra-1881	116	21	radical	radical	ADJ
gra-1881	116	22	radiotherapy	radiotherapy	NOUN
gra-1881	116	23	for	for	ADP
gra-1881	116	24	head	head	NOUN
gra-1881	116	25	and	and	CCONJ
gra-1881	116	26	neck	neck	NOUN
gra-1881	116	27	cancer	cancer	NOUN
gra-1881	116	28	:	:	PUNCT
gra-1881	116	29	a	a	DET
gra-1881	116	30	retrospective	retrospective	ADJ
gra-1881	116	31	comparision	comparision	NOUN
gra-1881	116	32	from	from	ADP
gra-1881	116	33	new	new	PROPN
gra-1881	116	34	cross	cross	PROPN
gra-1881	116	35	hospital	hospital	PROPN
gra-1881	116	36	,	,	PUNCT
gra-1881	116	37	wolverhampton	wolverhampton	PROPN
gra-1881	116	38	,	,	PUNCT
gra-1881	116	39	uk	uk	PROPN
gra-1881	116	40	.	.	PROPN
gra-1881	116	41	acta	acta	PROPN
gra-1881	116	42	oncol	oncol	PROPN
gra-1881	117	1	2008;47:1513	2008;47:1513	PROPN
gra-1881	117	2	-	-	SYM
gra-1881	117	3	8	8	NUM
gra-1881	117	4	.	.	NOUN
gra-1881	117	5	11	11	NUM
gra-1881	117	6	.	.	PUNCT
gra-1881	118	1	jemal	jemal	PROPN
gra-1881	118	2	a	a	DET
gra-1881	118	3	,	,	PUNCT
gra-1881	118	4	seigel	seigel	NOUN
gra-1881	118	5	r	r	NOUN
gra-1881	118	6	,	,	PUNCT
gra-1881	118	7	xu	xu	PROPN
gra-1881	118	8	j	j	PROPN
gra-1881	118	9	,	,	PUNCT
gra-1881	118	10	ward	ward	PROPN
gra-1881	118	11	e.	e.	PROPN
gra-1881	118	12	2010	2010	NUM
gra-1881	118	13	cancer	cancer	NOUN
gra-1881	118	14	statistics	statistic	NOUN
gra-1881	118	15	.	.	PUNCT
gra-1881	119	1	ca	can	AUX
gra-1881	119	2	cancer	cancer	PROPN
gra-1881	119	3	j	j	PROPN
gra-1881	119	4	clin	clin	PROPN
gra-1881	119	5	;	;	PUNCT
gra-1881	119	6	60:277	60:277	NUM
gra-1881	119	7	-	-	SYM
gra-1881	119	8	300	300	NUM
gra-1881	119	9	.	.	PUNCT
gra-1881	120	1	x	x	X
gra-1881	120	2	57gjra	57gjra	NUM
gra-1881	120	3	global	global	ADJ
gra-1881	120	4	journal	journal	PROPN
gra-1881	120	5	for	for	ADP
gra-1881	120	6	research	research	NOUN
gra-1881	120	7	analysis	analysis	NOUN
gra-1881	120	8	volume-9	volume-9	NUM
gra-1881	120	9	,	,	PUNCT
gra-1881	120	10	issue-2	issue-2	PROPN
gra-1881	120	11	,	,	PUNCT
gra-1881	120	12	february-2020	february-2020	VERB
gra-1881	120	13	•	•	NUM
gra-1881	120	14	print	print	NOUN
gra-1881	120	15	issn	issn	PROPN
gra-1881	120	16	no	no	NOUN
gra-1881	120	17	.	.	PROPN
gra-1881	120	18	2277	2277	NUM
gra-1881	120	19	8160	8160	NUM
gra-1881	120	20	•	•	NOUN
gra-1881	120	21	doi	doi	NOUN
gra-1881	120	22	:	:	PUNCT
gra-1881	120	23	10.36106	10.36106	NUM
gra-1881	120	24	/	/	SYM
gra-1881	120	25	gjra	gjra	NOUN